☰

Lindsay M. Morton, Ph.D. - Publications

Affiliations: 
2004 Yale University, New Haven, CT 
Area:
Public Health, Oncology
Tree Info Similar researchers PubMed Report error

202/344 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Gibson TM, Karyadi DM, Hartley SW, Arnold MA, Berrington de Gonzalez A, Conces MR, Howell RM, Kapoor V, Leisenring WM, Neglia JP, Sampson JN, Turcotte LM, Chanock SJ, Armstrong GT, Morton LM. Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors. Nature Medicine. PMID 38454124 DOI: 10.1038/s41591-024-02837-7  0.332
2023 Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, Smedby KE, Kleinstern G, Hjalgrim H, Besson C, Skibola CF, Morton LM, Brooks-Wilson AR, Teras LR, Breeze C, et al. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. PMID 37666943 DOI: 10.1038/s41375-023-01978-x  0.551
2022 Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, Smedby KE, Kleinstern G, Hjalgrim H, Besson C, Skibola CF, Morton LM, Brooks-Wilson AR, Teras LR, Breeze C, et al. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. PMID 36273105 DOI: 10.1038/s41375-022-01711-0  0.608
2021 Chihara D, Dores G, Flowers C, Morton LM. The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma. Blood. PMID 33822002 DOI: 10.1182/blood.2020010497  0.365
2020 Allodji RS, Tucker MA, Hawkins MM, Le Deley MC, Veres C, Weathers R, Howell R, Winter D, Haddy N, Rubino C, Diallo I, Little MP, Morton LM, de Vathaire F. Role of Radiotherapy and Chemotherapy in the Risk of Leukemia after Childhood Cancer: An International Pooled Analysis. International Journal of Cancer. PMID 33105035 DOI: 10.1002/ijc.33361  0.331
2020 Im C, Qin N, Wang Z, Qiu W, Howell CR, Sapkota Y, Moon W, Chemaitilly W, Gibson TM, Mulrooney DA, Ness KK, Wilson CL, Morton LM, Armstrong GT, Bhatia S, et al. Generalizability of "GWAS Hits" in Clinical Populations: Lessons from Childhood Cancer Survivors. American Journal of Human Genetics. PMID 32946765 DOI: 10.1016/J.Ajhg.2020.08.014  0.418
2020 Lin SH, Sampson JN, Grünewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, Zaidi S, Grossetête-Lalami S, Ballet S, Lapouble E, Laurence V, Michon J, Pierron G, ... ... Morton LM, et al. Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma. Plos One. 15: e0237792. PMID 32881892 DOI: 10.1371/Journal.Pone.0237792  0.368
2020 Withrow DR, Schonfeld SJ, Curtis RE, Morton LM, Cook MB, Butler EN, Berrington de González A. Racial and ethnic differences in risk of second primary cancers among prostate cancer survivors. Cancer Causes & Control : Ccc. PMID 32839916 DOI: 10.1007/S10552-020-01336-7  0.324
2020 Journy N, Schonfeld SJ, Hauptmann M, Roberti S, Howell RM, Smith SA, Vaalavirta L, Stovall M, van Leeuwen FE, Weathers RE, Hodgson D, Gilbert ES, Berrington de Gonzalez A, Morton LM. Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32679305 DOI: 10.1016/J.Radonc.2020.07.022  0.312
2020 D'Arcy ME, Castenson D, Lynch CF, Kahn AR, Morton LM, Shiels MS, Pfeiffer RM, Engels EA. Risk of rare cancers among solid organ transplant recipients. Journal of the National Cancer Institute. PMID 32462187 DOI: 10.1093/Jnci/Djaa078  0.344
2020 Mahale P, Ugoji C, Engels EA, Shiels MS, Peprah S, Morton LM. Cancer risk following lymphoid malignancies among HIV-infected people. Aids (London, England). PMID 32287068 DOI: 10.1097/Qad.0000000000002528  0.345
2020 Mirabello L, Zhu B, Koster R, Karlins E, Dean M, Yeager M, Gianferante M, Spector LG, Morton LM, Karyadi D, Robison LL, Armstrong GT, Bhatia S, Song L, Pankratz N, et al. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. Jama Oncology. PMID 32191290 DOI: 10.1001/Jamaoncol.2020.0197  0.305
2020 Dalal NH, Dores GM, Curtis RE, Linet MS, Morton LM. Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016. British Journal of Haematology. PMID 32090327 DOI: 10.1111/Bjh.16492  0.309
2020 Richard MA, Lupo PJ, Morton LM, Yasui YA, Sapkota YA, Arnold MA, Aubert G, Neglia JP, Turcotte LM, Leisenring WM, Sampson JN, Chanock SJ, Hudson MM, Armstrong GT, Robison LL, et al. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study. Plos One. 15: e0228887. PMID 32040538 DOI: 10.1371/Journal.Pone.0228887  0.402
2020 Im C, Li N, Moon W, Morton LM, Leisenring WM, Howell RM, Oeffinger KC, Sklar CA, Wilson CL, Sapkota Y, Ness KK, Hudson MM, Robison LL, Bhatia S, Armstrong GT, et al. HAGHL genetic variants increase first fracture risk (FFR) in female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime Cohort Study (SJLIFE). Journal of Clinical Oncology. 38: 10554-10554. DOI: 10.1200/Jco.2020.38.15_Suppl.10554  0.406
2020 Trendowski MR, Baedke J, Sapkota Y, El Charif O, Wheeler HE, Leisenring WM, Robison LL, Hudson MM, Morton LM, Oeffinger KC, Travis LB, Howell RM, Yasui Y, Armstrong GT, Bhatia S, et al. Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the childhood cancer survivor study and the St. Jude Lifetime Cohort. Journal of Clinical Oncology. 38: 10550-10550. DOI: 10.1200/Jco.2020.38.15_Suppl.10550  0.369
2019 Schonfeld SJ, Merino DM, Curtis RE, de González AB, Herr MM, Kleinerman RA, Savage SA, Tucker MA, Morton LM. Risk of Second Primary Bone and Soft-Tissue Sarcomas Among Young Adulthood Cancer Survivors. Jnci Cancer Spectrum. 3: pkz043. PMID 32566895 DOI: 10.1093/Jncics/Pkz043  0.427
2019 Moore A, Kane E, Wang Z, Panagiotou OA, Teras LR, Monnereau A, Wong Doo N, Machiela MJ, Skibola CF, Slager SL, Salles G, Camp NJ, Bracci PM, Nieters A, Vermeulen RCH, ... ... Morton LM, et al. Genetically Determined Height and Risk of Non-hodgkin Lymphoma. Frontiers in Oncology. 9: 1539. PMID 32064237 DOI: 10.3389/Fonc.2019.01539  0.68
2019 Schonfeld SJ, Morton LM, de González AB, Curtis RE, Kitahara CM. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015. Cancer Epidemiology. 64: 101664. PMID 31884334 DOI: 10.1016/J.Canep.2019.101664  0.357
2019 Veiga LH, Curtis RE, Morton LM, Withrow DR, Howell RM, Smith SA, Weathers RE, Oeffinger KC, Moskowitz CS, Henderson TO, Arnold MA, Gibson TM, Leisenring WM, Neglia JP, Turcotte LM, et al. Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study. Jama Pediatrics. PMID 31657853 DOI: 10.1001/Jamapediatrics.2019.3807  0.364
2019 Kleinerman RA, Schonfeld SJ, Sigel BS, Wong-Siegel JR, Gilbert ES, Abramson DH, Seddon JM, Tucker MA, Morton LM. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901096. PMID 31622129 DOI: 10.1200/Jco.19.01096  0.333
2019 Din L, Sheikh M, Kosaraju N, Smedby KE, Bernatsky S, Berndt SI, Skibola CF, Nieters A, Wang S, McKay JD, Cocco P, Maynadié M, Foretová L, Staines A, Mack TM, ... ... Morton L, et al. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. Genetic Epidemiology. PMID 31407831 DOI: 10.1002/Gepi.22242  0.631
2019 Advani PG, Schonfeld SJ, Curtis RE, Dores GM, Linet MS, Sigel BS, Lam CJK, Tucker MA, Chanock SJ, Morton LM. Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study. Leukemia. PMID 31341236 DOI: 10.1038/S41375-019-0520-Y  0.346
2019 Herr MM, Schonfeld SJ, Dores GM, Engels EA, Tucker MA, Curtis RE, Morton LM. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes. Blood Advances. 3: 1961-1969. PMID 31262739 DOI: 10.1182/Bloodadvances.2019030924  0.374
2019 Moskowitz CS, Chou JF, Neglia JP, Partridge AH, Howell RM, Diller LR, Novetsky Friedman D, Barnea D, Morton LM, Turcotte LM, Arnold MA, Leisenring WM, Armstrong GT, Robison LL, Oeffinger KC, et al. Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1802219. PMID 31260644 DOI: 10.1200/Jco.18.02219  0.321
2019 Sapkota Y, Turcotte LM, Ehrhardt MJ, Howell RM, Arnold MA, Wilson CL, Leisenring W, Wang Z, Sampson J, Dagnall CL, Karlins E, Li SA, Hicks BD, Weathers R, Smith SA, ... ... Morton LM, et al. Genome-wide association study in irradiated childhood cancer survivors identifies HTR2A for subsequent basal cell carcinoma. The Journal of Investigative Dermatology. PMID 30910758 DOI: 10.1016/J.Jid.2019.02.029  0.325
2019 Dalal NH, Dores G, Curtis RE, Linet MS, Morton LM. Cause-specific mortality in survivors of lymphoplasmacytic lymphoma (LPL) and waldenstrom macroglobulinemia (WM). Journal of Clinical Oncology. 37: e19056-e19056. DOI: 10.1200/Jco.2019.37.15_Suppl.E19056  0.4
2019 Sapkota Y, Liu Q, Shelton KC, Wang X, Wilson CL, Wang Z, Mulrooney DA, Jefferies JL, Oeffinger KC, Morton LM, Zhang J, Armstrong GT, Bhatia S, Hudson MM, Robison LL, et al. Genome-wide association study using whole-genome sequencing to identify a novel locus associated with cardiomyopathy risk in adult survivors of childhood cancer: Utility of a two-stage analytic approach. Journal of Clinical Oncology. 37: 1516-1516. DOI: 10.1200/Jco.2019.37.15_Suppl.1516  0.463
2019 Wang Z, Liu Q, Wilson CL, Sapkota Y, Gibson TM, Morton LM, Sampson JN, Neglia JP, Arnold MA, Rusch MC, Mulder H, Easton J, Zhang J, Downing J, Bhatia S, et al. Polygenic risk of subsequent thyroid cancer after childhood cancer: A report from St. Jude lifetime cohort (SJLIFE) and Childhood Cancer Survivor Study (CCSS). Journal of Clinical Oncology. 37: 10060-10060. DOI: 10.1200/Jco.2019.37.15_Suppl.10060  0.445
2019 Veiga LHS, Curtis RE, Morton LM, Withrow D, Howell RM, Smith SA, Weathers R, Oeffinger KC, Moskowitz CS, Henderson TO, Arnold MA, Gibson TM, Leisenring W, Neglia JP, Turcotte LM, et al. Combined effect of radiotherapy and anthracyclines on risk of breast cancer among female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS). Journal of Clinical Oncology. 37: 10053-10053. DOI: 10.1200/Jco.2019.37.15_Suppl.10053  0.363
2019 Morton LM, Karyadi DM, Hartley S, Frone M, Sampson JN, Howell RM, Neglia JP, Arnold MA, Dagnall CL, Hicks B, Kristine J, Zhu B, Leisenring WM, Yasui Y, Bhatia S, et al. Subsequent neoplasm risk associated with rare variants in DNA repair and clinical radiation sensitivity syndrome genes: A report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 37: 10028-10028. DOI: 10.1200/Jco.2019.37.15_Suppl.10028  0.416
2019 Wang X, Chen Y, Hageman L, Singh P, Landier W, Blanco JG, Hawkins DS, Ritchey AK, Ginsberg JP, Winick NJ, Sapkota Y, Yasui Y, Morton LM, Armstrong GT, Oeffinger KC, et al. Risk prediction of anthracycline-related cardiomyopathy (AC) in childhood cancer survivors (CCS): A COG-ALTE03N1 and CCSS report. Journal of Clinical Oncology. 37: 10015-10015. DOI: 10.1200/Jco.2019.37.15_Suppl.10015  0.45
2019 Bolton K, Ptashkin R, Braunstein L, Gao T, Devlin SM, Kelly D, Coombs C, Patel M, Moarii M, Bernard E, Berthon A, Boucai L, Glodzik D, Martin A, Stadler Z, ... ... Morton L, et al. Abstract LB-304: Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-304  0.32
2019 Richard MA, Lupo PJ, Morton LM, Yasui Y, Arnold MA, Neglia JP, Turcotte LM, Leisenring WM, Chanock SJ, Sampson JN, Armstrong GT, Robison LL, Bhatia S, Gramatges MM. Abstract 3122: A functionalPOT1variant and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study Cancer Research. 79: 3122-3122. DOI: 10.1158/1538-7445.Am2019-3122  0.44
2018 Kim J, Luo W, Wang M, Wegman-Ostrosky T, Frone MN, Johnston JJ, Nickerson ML, Rotunno M, Li SA, Achatz MI, Brodie SA, Dean M, de Andrade KC, Fortes FP, Gianferante M, ... ... Morton LM, et al. Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls. Genome Medicine. 10: 99. PMID 30583724 DOI: 10.1186/S13073-018-0607-5  0.335
2018 Gramatges MM, Morton LM, Yasui Y, Arnold MA, Neglia JP, Leisenring WM, Machiela MJ, Dagnall CL, Chanock SJ, Armstrong GT, Robison LL, Bhatia S, Lupo PJ. Telomere length-associated genetic variants and the risk of thyroid cancer in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30377209 DOI: 10.1158/1055-9965.Epi-18-0972  0.347
2018 McMaster ML, Berndt SI, Zhang J, Slager SL, Li SA, Vajdic CM, Smedby KE, Yan H, Birmann BM, Brown EE, Smith A, Kleinstern G, Fansler MM, Mayr C, Zhu B, ... ... Morton LM, et al. Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia. Nature Communications. 9: 4182. PMID 30305637 DOI: 10.1038/S41467-018-06541-2  0.681
2018 Machiela MJ, Grünewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, Zaidi S, Grossetete-Lalami S, Ballet S, Lapouble E, Laurence V, Michon J, Pierron G, Kovar H, ... ... Morton LM, et al. Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. Nature Communications. 9: 3184. PMID 30093639 DOI: 10.1038/S41467-018-05537-2  0.437
2018 Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, ... ... Morton LM, et al. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. The Lancet. Haematology. PMID 29907552 DOI: 10.1016/S2352-3026(18)30051-6  0.319
2018 Turcotte LM, Neglia JP, Reulen RC, Ronckers CM, van Leeuwen FE, Morton LM, Hodgson DC, Yasui Y, Oeffinger KC, Henderson TO. Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017767764. PMID 29874133 DOI: 10.1200/Jco.2017.76.7764  0.429
2018 Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez A, van den Heuvel-Eibrink MM, Kremer LCM, Gilbert ES, van Leeuwen FE, Ronckers CM, Morton LM. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014. Leukemia. PMID 29795414 DOI: 10.1038/S41375-018-0149-2  0.424
2018 Wang SS, Carrington M, Berndt SI, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Ekström Smedby K, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, et al. HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes. Cancer Research. PMID 29735552 DOI: 10.1158/0008-5472.Can-17-2900  0.624
2018 Kleinstern G, Camp NJ, Goldin LR, Vachon CM, Vajdic CM, de Sanjose S, Weinberg JB, Benavente Y, Casabonne D, Liebow M, Nieters A, Hjalgrim H, Melbye M, Glimelius B, Adami HO, ... ... Morton LM, et al. Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Blood. PMID 29674426 DOI: 10.1182/Blood-2017-11-814608  0.492
2018 Herr MM, Schonfeld SJ, Dores GM, Withrow DR, Tucker MA, Curtis RE, Morton LM. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival. Journal of the National Cancer Institute. PMID 29659938 DOI: 10.1093/Jnci/Djy052  0.388
2018 Brooke RJ, Im C, Wilson CL, Krasin MJ, Liu Q, Li Z, Sapkota Y, Moon W, Morton LM, Wu G, Wang Z, Chen W, Howell RM, Armstrong GT, Bhatia S, et al. A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy. Journal of the National Cancer Institute. PMID 29432556 DOI: 10.1093/Jnci/Djx281  0.395
2018 Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de González A. Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers. Jama Oncology. PMID 29346498 DOI: 10.1001/Jamaoncol.2017.4887  0.313
2018 Lupo PJ, Morton LM, Yasui Y, Leisenring WM, Armstrong GT, Robison LL, Bhatia S, Gramatges MM. Abstract 600: Telomere length-associated genetic variants and the risk of thyroid cancer after childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) Cancer Research. 78: 600-600. DOI: 10.1158/1538-7445.Am2018-600  0.431
2018 Machiela MJ, Grünewald TG, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, Zaidi S, Grossetete-Lalami S, Ballet S, Lapouble E, Laurence V, Michon J, Pierron G, Kovar H, ... ... Morton LM, et al. Abstract 2970: Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma Epidemiology. DOI: 10.1158/1538-7445.Am2018-2970  0.324
2018 Lupo PJ, Morimoto L, Karlins E, Shao X, Morton LM, Scheurer ME, Bhatia S, Robison LL, Armstrong GT, Hettmer S, Khan J, Chanock SJ, Freedman ND, Wyatt K, Hicks BD, et al. Abstract 2966: A genome-wide scan identifies a new locus associated with pediatric rhabdomyosarcoma Cancer Research. 78: 2966-2966. DOI: 10.1158/1538-7445.Am2018-2966  0.437
2017 Bernatsky S, Velásquez García HA, Spinelli JJ, Gaffney P, Smedby KE, Ramsey-Goldman R, Wang SS, Adami HO, Albanes D, Angelucci E, Ansell SM, Asmann YW, Becker N, Benavente Y, Berndt SI, ... ... Morton LM, et al. Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma. Lupus Science & Medicine. 4: e000187. PMID 29214033 DOI: 10.1136/Lupus-2016-000187  0.655
2017 Morton LM, Sampson JN, Armstrong GT, Chen TH, Hudson MM, Karlins E, Dagnall CL, Li SA, Wilson CL, Srivastava DK, Liu W, Kang G, Oeffinger KC, Henderson TO, Moskowitz CS, et al. Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer. Journal of the National Cancer Institute. 109. PMID 29059430 DOI: 10.1093/Jnci/Djx058  0.349
2017 Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de González A. Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers. Breast Cancer Research and Treatment. PMID 28744752 DOI: 10.1007/S10549-017-4410-6  0.37
2017 Zamoiski R, Yanik EL, Gibson TM, Cahoon EK, Madeleine MM, Lynch CF, Gustafson S, Goodman MT, Skeans M, Israni A, Engels EA, Morton LM. Risk of second malignancies in solid organ transplant recipients who develop keratinocyte cancers. Cancer Research. PMID 28615224 DOI: 10.1158/0008-5472.Can-16-3291  0.426
2017 Law PJ, Berndt SI, Speedy HE, Camp NJ, Sava GP, Skibola CF, Holroyd A, Joseph V, Sunter NJ, Nieters A, Bea S, Monnereau A, Martin-Garcia D, Goldin LR, Clot G, ... ... Morton LM, et al. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nature Communications. 8: 14175. PMID 28165464 DOI: 10.1038/Ncomms14175  0.617
2017 Morton LM, Veiga L, Curtis RE, Withrow D, Inskip P, Oeffinger KC, Moskowitz CS, Neglia J, Turcotte LM, Howell RM, Weathers R, Smith SA, Henderson TO, Leisenring WM, Whitton J, et al. Risk of subsequent breast cancer after radiotherapy according to hormone-receptor status: A nested case-control study in the Childhood Cancer Survivor Study (CCSS). Journal of Clinical Oncology. 35: 10520-10520. DOI: 10.1200/Jco.2017.35.15_Suppl.10520  0.332
2017 Brooke RJ, Chemaitilly W, Wilson CL, Krasin MJ, Li Z, Im C, Morton LM, Wu G, Wang Z, Chen W, Howell RM, Armstrong GT, Bhatia S, Chanock SJ, Zhang J, et al. A high-risk genetic profile for premature menopause (PM) in childhood cancer survivors (CCS) exposed to gonadotoxic therapy: A report from the St. Jude Lifetime Cohort (SJLIFE) and Childhood Cancer Survivor Study (CCSS). Journal of Clinical Oncology. 35: 10502-10502. DOI: 10.1200/Jco.2017.35.15_Suppl.10502  0.446
2017 Besson C, Moore A, Wu W, Camp NJ, Vajdic C, Morton LM, Smedby KE, Sanjose Sd, Shanafelt TD, Brewer J, Zablotska L, Engels EA, Cerhan JR, Slager SL, Han J, et al. Common Genetic Polymorphisms Contribute to the Association between Non-Melanoma Skin Cancer and Chronic Lymphocytic Leukemia Blood. 130: 1454-1454. DOI: 10.1182/Blood.V130.Suppl_1.1454.1454  0.376
2017 Morton LM, Dores GM, Herr MM, Linet MS, Tucker MA, Curtis RE. Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013 Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-236  0.468
2017 McMaster ML, Berndt SI, Li SA, Slager S, Vijai J, Chung CC, Zhu B, Burdette L, Birmann B, Brown EE, Cerhan JR, Ekstrom-Smedby K, Hjalgrim H, Kleinstern G, Link BK, ... ... Morton LM, et al. Abstract 1318: A genome-wide association study of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma demonstrates association with chromosome 6 Epidemiology. 77: 1318-1318. DOI: 10.1158/1538-7445.Am2017-1318  0.333
2017 Wang Y, Habermann T, Wang S, Maurer M, Link B, Feldman A, Inwards D, Witzig T, Cozen W, Morton L, Rothman N, Chanock S, Slager S, Cerhan J. HOST GENETIC VARIATION IN THE TNF AND NF-ĸB PATHWAYS AND PROGNOSIS IN MANTLE CELL LYMPHOMA: AN ANALYSIS OF 2 STUDIES Hematological Oncology. 35: 151-152. DOI: 10.1002/Hon.2438_4  0.308
2016 Morton LM, Saber W, Baker KS, Barrett AJ, Bhatia S, Engels EA, Gadalla SM, Kleiner DE, Pavletic S, Burns LJ. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27634019 DOI: 10.1016/J.Bbmt.2016.09.005  0.357
2016 Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. Ca: a Cancer Journal For Clinicians. PMID 27618563 DOI: 10.3322/Caac.21357  0.369
2016 Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, ... ... Morton LM, et al. Increased pancreatic cancer risk following radiotherapy for testicular cancer. British Journal of Cancer. PMID 27599043 DOI: 10.1038/Bjc.2016.272  0.351
2016 Engels EA, Parsons R, Besson C, Morton LM, Enewold L, Ricker W, Yanik EL, Arem H, Austin AA, Pfeiffer RM. Comprehensive evaluation of medical conditions associated with risk of non-Hodgkin lymphoma using Medicare claims ("MedWAS"). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197296 DOI: 10.1158/1055-9965.Epi-16-0212  0.367
2016 Srour SA, Devesa SS, Morton LM, Check DP, Curtis RE, Linet MS, Dores GM. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12. British Journal of Haematology. PMID 27061824 DOI: 10.1111/Bjh.14061  0.326
2016 Machiela MJ, Lan Q, Slager SL, Vermeulen RC, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A, Vijai J, Yeager M, Wang Z, Ghesquières H, McKay J, ... ... Morton LM, et al. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Human Molecular Genetics. 25: 1663-76. PMID 27008888 DOI: 10.1093/Hmg/Ddw027  0.675
2016 Bassig BA, Au WY, Mang O, Ngan R, Morton LM, Ip DK, Hu W, Zheng T, Seow WJ, Xu J, Lan Q, Rothman N. Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001-2010. Cancer Epidemiology. 42: 15-23. PMID 26991956 DOI: 10.1016/J.Canep.2016.02.007  0.489
2016 Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, Nieters A, Kelly RS, Smedby KE, Monnereau A, Cozen W, Cox A, Wang SS, Lan Q, Teras LR, ... ... Morton LM, et al. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nature Communications. 7: 10933. PMID 26956414 DOI: 10.1038/Ncomms10933  0.622
2016 Merino DM, Curtis RE, Berrington De Gonzalez A, Tucker MA, Morton LM. Spectrum of pediatric and young adult cancer survivors at risk of developing subsequent sarcomas. Journal of Clinical Oncology. 34: 10572-10572. DOI: 10.1200/Jco.2016.34.15_Suppl.10572  0.378
2016 Morton LM, Sampson JN, Bhatia S, Hudson MM, Chen T, Neglia JP, Yasui Y, Karlins E, Dagnall CL, Gibson TM, Wilson CL, Srivastava DK, Liu W, Kang G, Weathers R, et al. Genome-wide association study of meningioma as a subsequent neoplasm: A report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime Cohort (SJLIFE). Journal of Clinical Oncology. 34: 10510-10510. DOI: 10.1200/Jco.2016.34.15_Suppl.10510  0.396
2016 Morton LM, Herr MM, Schonfeld SJ, Dores GM, Curtis RE, Tucker MA. Patterns of Cutaneous Malignancy Risk Among Survivors of Non-Hodgkin Lymphoma Subtypes Blood. 128: 4771-4771. DOI: 10.1182/Blood.V128.22.4771.4771  0.456
2016 Herr MM, Schonfeld SJ, Dores GM, Tucker MA, Curtis RE, Morton LM. Risk for New Malignancies of Potential Infectious Etiology Among Adult Survivors of Specific Non-Hodgkin Lymphoma Subtypes Blood. 128: 2414-2414. DOI: 10.1182/Blood.V128.22.2414.2414  0.455
2016 Bassig BA, Au W, Mang O, Ngan R, Morton LM, Ip DKM, Hu W, Zheng T, Seow WJ, Xu J, Rothman N, Lan Q. Abstract 5206: Recent incidence trends of lymphoid malignancies in Hong Kong, 2001-2010 Cancer Research. 76: 5206-5206. DOI: 10.1158/1538-7445.Am2016-5206  0.408
2015 Hussain SK, Makgoeng SB, Everly MJ, Goodman MT, Martínez-Maza O, Morton LM, Clarke CA, Lynch CF, Snyder J, Israni A, Kasiske BL, Engels EA. HLA and Risk of Diffuse Large B-cell Lymphoma After Solid Organ Transplantation. Transplantation. PMID 26636741 DOI: 10.1097/Tp.0000000000001025  0.366
2015 DellaValle CT, Deziel NC, Jones RR, Colt JS, De Roos AJ, Cerhan JR, Cozen W, Severson RK, Flory AR, Morton LM, Ward MH. Polycyclic aromatic hydrocarbons: determinants of residential carpet dust levels and risk of non-Hodgkin lymphoma. Cancer Causes & Control : Ccc. PMID 26573845 DOI: 10.1007/S10552-015-0660-Y  0.434
2015 Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, Vivo ID, ... ... Morton LM, et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Journal of the National Cancer Institute. 107. PMID 26464424 DOI: 10.1093/Jnci/Djv279  0.715
2015 Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM. Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma. Leukemia. PMID 26369985 DOI: 10.1038/Leu.2015.248  0.369
2015 Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26240221 DOI: 10.1200/Jco.2014.60.2094  0.35
2015 Grünewald TG, Bernard V, Gilardi-Hebenstreit P, Raynal V, Surdez D, Aynaud MM, Mirabeau O, Cidre-Aranaz F, Tirode F, Zaidi S, Perot G, Jonker AH, Lucchesi C, Le Deley MC, Oberlin O, ... ... Morton LM, et al. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite. Nature Genetics. 47: 1073-1078. PMID 26214589 DOI: 10.1038/Ng.3363  0.405
2015 Nordsborg RB, Sloan CD, Shahid H, Jacquez GM, De Roos AJ, Cerhan JR, Cozen W, Severson R, Ward MH, Morton L, Raaschou-Nielsen O, Meliker JR. Investigation of spatio-temporal cancer clusters using residential histories in a case-control study of non-Hodgkin lymphoma in the United States. Environmental Health : a Global Access Science Source. 14: 48. PMID 26043768 DOI: 10.1186/S12940-015-0034-7  0.329
2015 Kane E, Skibola CF, Bracci PM, Cerhan JR, Costas L, Smedby KE, Holly EA, Maynadié M, Novak AJ, Lightfoot TJ, Ansell SM, Smith AG, Liebow M, Melbye M, Morton L, et al. Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1061-70. PMID 25962811 DOI: 10.1158/1055-9965.Epi-14-1355  0.578
2015 Wang SS, Vajdic CM, Linet MS, Slager SL, Voutsinas J, Nieters A, de Sanjose S, Cozen W, Alarcón GS, Martinez-Maza O, Brown EE, Bracci PM, Lightfoot T, Turner J, Hjalgrim H, ... ... Morton LM, et al. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. American Journal of Epidemiology. 181: 406-21. PMID 25713336 DOI: 10.1093/Aje/Kwu290  0.672
2015 Berrington de Gonzalez A, Wong J, Kleinerman R, Kim C, Morton L, Bekelman JE. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors. International Journal of Radiation Oncology, Biology, Physics. 91: 295-302. PMID 25636756 DOI: 10.1016/J.Ijrobp.2014.10.040  0.353
2015 Vijai J, Wang Z, Berndt SI, Skibola CF, Slager SL, de Sanjose S, Melbye M, Glimelius B, Bracci PM, Conde L, Birmann BM, Wang SS, Brooks-Wilson AR, Lan Q, de Bakker PI, ... ... Morton LM, et al. A genome-wide association study of marginal zone lymphoma shows association to the HLA region. Nature Communications. 6: 5751. PMID 25569183 DOI: 10.1038/Ncomms6751  0.662
2015 Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, ... ... Morton LM, et al. Increased stomach cancer risk following radiotherapy for testicular cancer. British Journal of Cancer. 112: 44-51. PMID 25349972 DOI: 10.1038/Bjc.2014.552  0.355
2015 Srour SA, Devesa SS, Morton LM, Check DP, Curtis RE, Linet MS, Dores GM. Incidence and Patient Survival of Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs) in the United States: A Population-Based View of the Modern Diagnostic Era Blood. 126: 2806-2806. DOI: 10.1182/Blood.V126.23.2806.2806  0.341
2015 Lam C, Curtis R, Dores G, Engels E, Caporaso N, Polliack A, Warren J, Young H, Levine P, Elmi A, Fraumeni J, Tucker M, Morton L. Abstract LB-184: Risk factors for lung cancer among survivors of non-Hodgkin lymphoma Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-184  0.458
2015 Hofmann JN, Birmann BM, Teras LR, Wang Y, Albanes D, Baris D, Colditz GA, Roos AJD, Giles GG, Morton LM, Hosgood HD, Lan Q, Landgren O, Liao LM, Pfeiffer RM, et al. Abstract 934: A pooled investigation of circulating adiponectin levels and risk of multiple myeloma Cancer Research. 75: 934-934. DOI: 10.1158/1538-7445.Am2015-934  0.443
2015 Liu JJ, Morton LM, González ABd, Inskip PD, Curtis RE. Abstract 3725: Subsequent gastrointestinal cancer risks of childhood and early adulthood cancer survivors Cancer Research. 75: 3725-3725. DOI: 10.1158/1538-7445.Am2015-3725  0.383
2014 Shiels MS, Gibson T, Sampson J, Albanes D, Andreotti G, Beane Freeman L, Berrington de Gonzalez A, Caporaso N, Curtis RE, Elena J, Freedman ND, Robien K, Black A, Morton LM. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3989-95. PMID 25385740 DOI: 10.1200/Jco.2014.56.8220  0.328
2014 Skibola CF, Berndt SI, Vijai J, Conde L, Wang Z, Yeager M, de Bakker PI, Birmann BM, Vajdic CM, Foo JN, Bracci PM, Vermeulen RC, Slager SL, de Sanjose S, Wang SS, ... ... Morton LM, et al. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region. American Journal of Human Genetics. 95: 462-71. PMID 25279986 DOI: 10.1016/J.Ajhg.2014.09.004  0.634
2014 Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, et al. Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma. Haematologica. 99: e193-6. PMID 25271315 DOI: 10.3324/haematol.2014.108258  0.328
2014 Gibson TM, Park Y, Robien K, Shiels MS, Black A, Sampson JN, Purdue MP, Freeman LE, Andreotti G, Weinstein SJ, Albanes D, Fraumeni JF, Curtis RE, Berrington de Gonzalez A, Morton LM. Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 4004-11. PMID 25267739 DOI: 10.1200/Jco.2014.56.8444  0.334
2014 Cerhan JR, Berndt SI, Vijai J, Ghesquières H, McKay J, Wang SS, Wang Z, Yeager M, Conde L, de Bakker PI, Nieters A, Cox D, Burdett L, Monnereau A, Flowers CR, ... ... Morton LM, et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nature Genetics. 46: 1233-8. PMID 25261932 DOI: 10.1038/Ng.3105  0.603
2014 Wong JR, Morton LM, Tucker MA, Abramson DH, Seddon JM, Sampson JN, Kleinerman RA. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3284-90. PMID 25185089 DOI: 10.1200/Jco.2013.54.7844  0.411
2014 Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 130-44. PMID 25174034 DOI: 10.1093/Jncimonographs/Lgu013  0.62
2014 Skibola CF, Slager SL, Berndt SI, Lightfoot T, Sampson JN, Morton LM, Weisenburger DD. Medical history, lifestyle, family history, and occupational risk factors for adult acute lymphocytic leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 125-9. PMID 25174033 DOI: 10.1093/Jncimonographs/Lgu009  0.379
2014 Monnereau A, Slager SL, Hughes AM, Smith A, Glimelius B, Habermann TM, Berndt SI, Staines A, Norman AD, Cerhan JR, Sampson JN, Morton LM, Clavel J. Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 115-24. PMID 25174032 DOI: 10.1093/Jncimonographs/Lgu004  0.398
2014 Mbulaiteye SM, Morton LM, Sampson JN, Chang ET, Costas L, de Sanjosé S, Lightfoot T, Kelly J, Friedberg JW, Cozen W, Marcos-Gragera R, Slager SL, Birmann BM, Weisenburger DD. Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 106-14. PMID 25174031 DOI: 10.1093/Jncimonographs/Lgu003  0.392
2014 Aschebrook-Kilfoy B, Cocco P, La Vecchia C, Chang ET, Vajdic CM, Kadin ME, Spinelli JJ, Morton LM, Kane EV, Sampson JN, Kasten C, Feldman AL, Wang SS, Zhang Y. Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 98-105. PMID 25174030 DOI: 10.1093/Jncimonographs/Lgu008  0.485
2014 Vajdic CM, Landgren O, McMaster ML, Slager SL, Brooks-Wilson A, Smith A, Staines A, Dogan A, Ansell SM, Sampson JN, Morton LM, Linet MS. Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 87-97. PMID 25174029 DOI: 10.1093/Jncimonographs/Lgu002  0.408
2014 Wang SS, Flowers CR, Kadin ME, Chang ET, Hughes AM, Ansell SM, Feldman AL, Lightfoot T, Boffetta P, Melbye M, Lan Q, Sampson JN, Morton LM, Zhang Y, Weisenburger DD. Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 66-75. PMID 25174027 DOI: 10.1093/Jncimonographs/Lgu012  0.526
2014 Bracci PM, Benavente Y, Turner JJ, Paltiel O, Slager SL, Vajdic CM, Norman AD, Cerhan JR, Chiu BC, Becker N, Cocco P, Dogan A, Nieters A, Holly EA, Kane EV, ... ... Morton LM, et al. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 52-65. PMID 25174026 DOI: 10.1093/jncimonographs/lgu011  0.312
2014 Linet MS, Vajdic CM, Morton LM, de Roos AJ, Skibola CF, Boffetta P, Cerhan JR, Flowers CR, de Sanjosé S, Monnereau A, Cocco P, Kelly JL, Smith AG, Weisenburger DD, Clarke CA, et al. Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 26-40. PMID 25174024 DOI: 10.1093/Jncimonographs/Lgu006  0.542
2014 Cerhan JR, Kricker A, Paltiel O, Flowers CR, Wang SS, Monnereau A, Blair A, Dal Maso L, Kane EV, Nieters A, Foran JM, Miligi L, Clavel J, Bernstein L, Rothman N, ... ... Morton LM, et al. Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 15-25. PMID 25174023 DOI: 10.1093/Jncimonographs/Lgu010  0.415
2014 Morton LM, Sampson JN, Cerhan JR, Turner JJ, Vajdic CM, Wang SS, Smedby KE, de Sanjosé S, Monnereau A, Benavente Y, Bracci PM, Chiu BC, Skibola CF, Zhang Y, Mbulaiteye SM, et al. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 1-14. PMID 25174022 DOI: 10.1093/Jncimonographs/Lgu005  0.526
2014 Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. Aids (London, England). 28: 2313-8. PMID 25111081 DOI: 10.1097/Qad.0000000000000428  0.371
2014 Morton LM. Triple jeopardy for Hodgkin lymphoma survivors? Blood. 124: 309-10. PMID 25035144 DOI: 10.1182/Blood-2014-05-571646  0.342
2014 Black A, Gibson TM, Shiels MS, Park Y, Robien K, Albanes D, Weinstein SJ, Freeman LE, Andreotti G, Purdue MP, Fraumeni JF, Hartge P, Tucker MA, Hoover RN, Cerhan JR, ... ... Morton LM, et al. Pooling prospective studies to investigate the etiology of second cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1598-608. PMID 24832874 DOI: 10.1158/1055-9965.Epi-14-0191  0.326
2014 Gibson TM, Engels EA, Clarke CA, Lynch CF, Weisenburger DD, Morton LM. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. American Journal of Hematology. 89: 714-20. PMID 24753070 DOI: 10.1002/Ajh.23726  0.383
2014 Morton LM, Gibson TM, Clarke CA, Lynch CF, Anderson LA, Pfeiffer R, Landgren O, Weisenburger DD, Engels EA. Risk of myeloid neoplasms after solid organ transplantation. Leukemia. 28: 2317-23. PMID 24727673 DOI: 10.1038/Leu.2014.132  0.347
2014 Lam CJ, Curtis RE, Dores G, Engels EA, Caporaso N, Polliack A, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM. Risk factors for melanoma among survivors of non-Hodgkin lymphoma in the U.S. elderly population. Journal of Clinical Oncology. 32: 1533-1533. DOI: 10.1200/Jco.2014.32.15_Suppl.1533  0.463
2014 Wong JR, Morton LM, Tucker MA, Abramson DH, Seddon J, Sampson J, Kleinerman R. Risk of subsequent malignant neoplasms in long-term retinoblastoma survivors following chemotherapy and radiotherapy. Journal of Clinical Oncology. 32: 10079-10079. DOI: 10.1200/Jco.2014.32.15_Suppl.10079  0.43
2013 Morton LM, Freedman DM. Shedding light on UVR and Hodgkin lymphoma. Blood. 122: 3395-7. PMID 24235128 DOI: 10.1182/Blood-2013-09-527648  0.387
2013 Bretherick KL, Schuetz JM, Morton LM, Purdue MP, Conde L, Gallagher RP, Connors JM, Gascoyne RD, Berry BR, Armstrong B, Kricker A, Vajdic CM, Grulich A, Hjalgrim H, Smedby KE, et al. Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma. Plos One. 8: e74619. PMID 24069324 DOI: 10.1371/Journal.Pone.0074619  0.463
2013 Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, et al. Stomach cancer risk after treatment for hodgkin lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3369-77. PMID 23980092 DOI: 10.1200/Jco.2013.50.6832  0.401
2013 Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, ... ... Morton LM, et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nature Genetics. 45: 868-76. PMID 23770605 DOI: 10.1038/Ng.2652  0.584
2013 Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, Weisenburger DD, Martínez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA. Risk of lymphoma subtypes after solid organ transplantation in the United States. British Journal of Cancer. 109: 280-8. PMID 23756857 DOI: 10.1038/Bjc.2013.294  0.388
2013 Engels EA, Clarke CA, Pfeiffer RM, Lynch CF, Weisenburger DD, Gibson TM, Landgren O, Morton LM. Plasma cell neoplasms in US solid organ transplant recipients. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 13: 1523-32. PMID 23635036 DOI: 10.1111/Ajt.12234  0.351
2013 Kabat GC, Wu JW, Moore SC, Morton LM, Park Y, Hollenbeck AR, Rohan TE. Lifestyle and dietary factors in relation to risk of chronic myeloid leukemia in the NIH-AARP Diet and Health Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 848-54. PMID 23625904 DOI: 10.1158/1055-9965.Epi-13-0093  0.333
2013 Pronk A, Nuckols JR, De Roos AJ, Airola M, Colt JS, Cerhan JR, Morton L, Cozen W, Severson R, Blair A, Cleverly D, Ward MH. Residential proximity to industrial combustion facilities and risk of non-Hodgkin lymphoma: a case-control study. Environmental Health : a Global Access Science Source. 12: 20. PMID 23433489 DOI: 10.1186/1476-069X-12-20  0.392
2013 Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, Fraumeni JF, Curtis RE. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood. 121: 2996-3004. PMID 23412096 DOI: 10.1182/Blood-2012-08-448068  0.409
2013 Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD, Lynch CF, Goodman MT, Engels EA. Burkitt lymphoma risk in U.S. solid organ transplant recipients. American Journal of Hematology. 88: 245-50. PMID 23386365 DOI: 10.1002/Ajh.23385  0.366
2013 Wang J, Cozen W, Thorne PS, Berhane K, Cerhan JR, Hartge P, Ward MH, De Roos AJ, Severson RK, Morton LM, Bernstein L, Linet MS, Colt JS. Household endotoxin levels and the risk of non-Hodgkin lymphoma. Cancer Causes & Control : Ccc. 24: 357-64. PMID 23277417 DOI: 10.1007/S10552-012-0121-9  0.362
2013 Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard-Barbash R, Bhatia S, Cerhan JR, Hartge P, Heist RS, Kushi LH, Lash TL, Morton LM, Onel K, Pierce JP, Robison LL, et al. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. Journal of the National Cancer Institute. 105: 85-94. PMID 23197494 DOI: 10.1093/Jnci/Djs473  0.327
2013 Kim CJ, Freedman DM, Curtis RE, Berrington de Gonzalez A, Morton LM. Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers. Leukemia & Lymphoma. 54: 1691-7. PMID 23193978 DOI: 10.3109/10428194.2012.753543  0.46
2013 Gibson TM, Smedby KE, Skibola CF, Hein DW, Slager SL, de Sanjosé S, Vajdic CM, Zhang Y, Chiu BC, Wang SS, Hjalgrim H, Nieters A, Bracci PM, Kricker A, Zheng T, ... ... Morton LM, et al. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium. Cancer Causes & Control : Ccc. 24: 125-34. PMID 23160945 DOI: 10.1007/S10552-012-0098-4  0.599
2013 Berrington de Gonzalez A, Gilbert E, Curtis R, Inskip P, Kleinerman R, Morton L, Rajaraman P, Little MP. Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship. International Journal of Radiation Oncology, Biology, Physics. 86: 224-33. PMID 23102695 DOI: 10.1016/J.Ijrobp.2012.09.001  0.329
2012 Nieters A, Conde L, Slager SL, Brooks-Wilson A, Morton L, Skibola DR, Novak AJ, Riby J, Ansell SM, Halperin E, Shanafelt TD, Agana L, Wang AH, De Roos AJ, Severson RK, et al. PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood. 120: 4645-8. PMID 23047821 DOI: 10.1182/Blood-2012-05-427989  0.678
2012 Daniel CR, Sinha R, Park Y, Graubard BI, Hollenbeck AR, Morton LM, Cross AJ. Meat intake is not associated with risk of non-Hodgkin lymphoma in a large prospective cohort of U.S. men and women. The Journal of Nutrition. 142: 1074-80. PMID 22535761 DOI: 10.3945/Jn.112.158113  0.416
2012 Gibson TM, Wang SS, Cerhan JR, Maurer MJ, Hartge P, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Morton LM. Inherited genetic variation and overall survival following follicular lymphoma. American Journal of Hematology. 87: 724-6. PMID 22473939 DOI: 10.1002/Ajh.23184  0.406
2012 Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 119: 34-43. PMID 22086414 DOI: 10.1182/Blood-2011-04-347872  0.303
2012 Cerhan JR, Natkunam Y, Morton LM, Maurer MJ, Asmann Y, Habermann TM, Vasef MA, Cozen W, Lynch CF, Allmer C, Slager SL, Lossos IS, Chanock SJ, Rothman N, Hartge P, et al. LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era. Leukemia & Lymphoma. 53: 1105-12. PMID 22066713 DOI: 10.3109/10428194.2011.638717  0.418
2012 Gibson TM, Engels EA, Clarke CA, Pfeiffer RM, Lynch CF, Chang ET, Hall E, Weisenburger DD, Morton LM. Abstract 1025: Risk of diffuse large B-cell lymphoma in solid organ transplant recipients Cancer Research. 72: 1025-1025. DOI: 10.1158/1538-7445.Am2012-1025  0.406
2011 Lu Y, Abdou AM, Cerhan JR, Morton LM, Severson RK, Davis S, Cozen W, Rothman N, Bernstein L, Chanock S, Hartge P, Wang SS. Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Thescientificworldjournal. 11: 2062-70. PMID 22125456 DOI: 10.1100/2011/373876  0.397
2011 Wang SS, Lu Y, Rothman N, Abdou AM, Cerhan JR, De Roos A, Davis S, Severson RK, Cozen W, Chanock SJ, Bernstein L, Morton LM, Hartge P. Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1. Plos One. 6: e26949. PMID 22096508 DOI: 10.1371/Journal.Pone.0026949  0.45
2011 Morton LM, Chanock SJ. A step toward slaying the hydra of second cancers. Nature Medicine. 17: 924-5. PMID 21818085 DOI: 10.1038/Nm.2428  0.368
2011 Koutros S, Silverman DT, Baris D, Zahm SH, Morton LM, Colt JS, Hein DW, Moore LE, Johnson A, Schwenn M, Cherala S, Schned A, Doll MA, Rothman N, Karagas MR. Hair dye use and risk of bladder cancer in the New England bladder cancer study. International Journal of Cancer. Journal International Du Cancer. 129: 2894-904. PMID 21678399 DOI: 10.1002/Ijc.26245  0.632
2011 Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, Hjalgrim H, Kumar V, Chang ET, Rothman N, Cerhan JR, Brooks-Wilson AR, Rehnberg E, Irwan ID, Ryder LP, Brown PN, ... ... Morton LM, et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. Plos Genetics. 7: e1001378. PMID 21533074 DOI: 10.1371/Journal.Pgen.1001378  0.667
2011 Shiels MS, Pfeiffer RM, Hall HI, Li J, Goedert JJ, Morton LM, Hartge P, Engels EA. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. Jama. 305: 1450-9. PMID 21486978 DOI: 10.1001/Jama.2011.396  0.34
2011 Lan Q, Wang SS, Menashe I, Armstrong B, Zhang Y, Hartge P, Purdue MP, Holford TR, Morton LM, Kricker A, Cerhan JR, Grulich A, Cozen W, Zahm SH, Yeager M, et al. Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. British Journal of Haematology. 153: 341-50. PMID 21418175 DOI: 10.1111/J.1365-2141.2010.08424.X  0.63
2011 Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer. 117: 1163-71. PMID 21381009 DOI: 10.1002/Cncr.25524  0.371
2011 Purdue MP, Bakke B, Stewart P, De Roos AJ, Schenk M, Lynch CF, Bernstein L, Morton LM, Cerhan JR, Severson RK, Cozen W, Davis S, Rothman N, Hartge P, Colt JS. A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma. Environmental Health Perspectives. 119: 232-8. PMID 21370516 DOI: 10.1289/Ehp.1002106  0.33
2011 Hosgood HD, Purdue MP, Wang SS, Zheng T, Morton LM, Lan Q, Menashe I, Zhang Y, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, et al. A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. British Journal of Haematology. 152: 721-6. PMID 21250972 DOI: 10.1111/J.1365-2141.2010.08518.X  0.767
2011 Wang SS, Menashe I, Cerhan JR, Cozen W, Severson RK, Davis S, Hutchinson A, Rothman N, Chanock SJ, Bernstein L, Hartge P, Morton LM. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 42-9. PMID 21148756 DOI: 10.1158/1055-9965.Epi-10-0638  0.449
2011 Chang CM, Wang SS, Dave BJ, Jain S, Vasef MA, Weisenburger DD, Cozen W, Davis S, Severson RK, Lynch CF, Rothman N, Cerhan JR, Hartge P, Morton LM. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. International Journal of Cancer. Journal International Du Cancer. 129: 938-47. PMID 20949561 DOI: 10.1002/Ijc.25717  0.369
2010 Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4935-44. PMID 20940199 DOI: 10.1200/Jco.2010.29.1112  0.438
2010 Shen M, Menashe I, Morton LM, Zhang Y, Armstrong B, Wang SS, Lan Q, Hartge P, Purdue MP, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. British Journal of Haematology. 151: 239-44. PMID 20813000 DOI: 10.1111/J.1365-2141.2010.08364.X  0.634
2010 Quinlan SC, Landgren O, Morton LM, Engels EA. Hodgkin lymphoma among US solid organ transplant recipients. Transplantation. 90: 1011-5. PMID 20733533 DOI: 10.1097/Tp.0B013E3181F5C3A6  0.321
2010 Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadié M, Chiu BC, Marcos-Gragera R, Costantini AS, Cerhan JR, Weisenburger DD. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 116: e90-8. PMID 20699439 DOI: 10.1182/Blood-2010-06-289561  0.305
2010 Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, Nieters A, Slager SL, Brooks-Wilson A, Agana L, Riby J, Liu J, Adami HO, Darabi H, Hjalgrim H, ... ... Morton LM, et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nature Genetics. 42: 661-4. PMID 20639881 DOI: 10.1038/Ng.626  0.65
2010 Geyer SM, Morton LM, Habermann TM, Allmer C, Davis S, Cozen W, Severson RK, Lynch CF, Wang SS, Maurer MJ, Hartge P, Cerhan JR. Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: A population-based study Cancer. 116: 2993-3000. PMID 20564404 DOI: 10.1002/Cncr.25114  0.307
2010 Troy JD, Hartge P, Weissfeld JL, Oken MM, Colditz GA, Mechanic LE, Morton LM. Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. American Journal of Epidemiology. 171: 1270-81. PMID 20494998 DOI: 10.1093/Aje/Kwq085  0.383
2010 Wang SS, Abdou AM, Morton LM, Thomas R, Cerhan JR, Gao X, Cozen W, Rothman N, Davis S, Severson RK, Bernstein L, Hartge P, Carrington M. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood. 115: 4820-3. PMID 20385791 DOI: 10.1182/Blood-2010-01-266775  0.413
2010 Kilfoy BA, Zheng T, Lan Q, Han X, Holford T, Hein DW, Qin Q, Leaderer B, Morton LM, Yeager M, Boyle P, Zhao P, Chanock S, Rothman N, Zhang Y. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma. Cancer Causes & Control : Ccc. 21: 127-33. PMID 19809881 DOI: 10.1007/S10552-009-9442-8  0.631
2010 Morton LM, Gilbert ES, Lynch CF, Hall P, Dores GM, Curtis RE, Storm HH, Johannesen TB, Stovall M, Smith SA, Weathers RE, Aleman BM, Kleinerman RA, Fraumeni JF, Holowaty EJ, et al. Risk of Treatment-Related Stomach Cancer Among Hodgkin Lymphoma Survivors Blood. 116: 2679-2679. DOI: 10.1182/blood.v116.21.2679.2679  0.312
2010 Wang SS, Menashe I, Cerhan JR, Rothman N, Severson RK, Davis S, Chanock SJ, Bernstein L, Hartge P, Morton L. Abstract 935: Genetic variants in chromosome 6p21.3 and risk of non-Hodgkin lymphoma Cancer Research. 70: 935-935. DOI: 10.1158/1538-7445.Am10-935  0.491
2010 Wang J, Colt JS, Thorne PS, Berhane KT, Richard SK, Davis S, Cerhan JR, Ward MH, Bernstein L, Morton LM, Patricia H, Cozen W. Abstract 5736: Household endotoxin levels and risk of non-Hodgkin lymphoma Epidemiology. 70: 5736-5736. DOI: 10.1158/1538-7445.Am10-5736  0.41
2010 Morton LM, Curtis RE, Engels EA, Caporaso N, Tucker MA, Warren JL, Fraumeni JF. Abstract 5644: Second cancer risks among lymphoma survivors in the SEER-Medicare linked dataset Cancer Research. 70: 5644-5644. DOI: 10.1158/1538-7445.Am10-5644  0.473
2009 Lan Q, Morton LM, Armstrong B, Hartge P, Menashe I, Zheng T, Purdue MP, Cerhan JR, Zhang Y, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, et al. Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood. 114: 264-7. PMID 19414860 DOI: 10.1182/Blood-2009-01-198697  0.667
2009 Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, Lan Q, Hartge P, Kricker A, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Grulich A, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. Plos One. 4: e5360. PMID 19390683 DOI: 10.1371/Journal.Pone.0005360  0.639
2009 Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, Berndt SI, Ricker W, Parsons R, Engels EA. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. International Journal of Cancer. Journal International Du Cancer. 125: 398-405. PMID 19365835 DOI: 10.1002/Ijc.24287  0.442
2009 Hosgood HD, Baris D, Zhang Y, Berndt SI, Menashe I, Morton LM, Lee KM, Yeager M, Zahm SH, Chanock S, Zheng T, Lan Q. Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk. Leukemia Research. 33: 1609-14. PMID 19362737 DOI: 10.1016/J.Leukres.2009.03.013  0.763
2009 Morton LM, Purdue MP, Zheng T, Wang SS, Armstrong B, Zhang Y, Menashe I, Chatterjee N, Davis S, Lan Q, Vajdic CM, Severson RK, Holford TR, Kricker A, Cerhan JR, et al. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1259-70. PMID 19336552 DOI: 10.1158/1055-9965.Epi-08-1037  0.674
2009 Colt JS, Rothman N, Severson RK, Hartge P, Cerhan JR, Chatterjee N, Cozen W, Morton LM, De Roos AJ, Davis S, Chanock S, Wang SS. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood. 113: 1899-905. PMID 19066394 DOI: 10.1182/Blood-2008-04-153858  0.401
2009 Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, Weinstein SJ, Morton LM, Schatzkin A, Virtamo J, Linet MS, Hartge P, Albanes D. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. International Journal of Cancer. Journal International Du Cancer. 124: 979-86. PMID 19035445 DOI: 10.1002/Ijc.23984  0.315
2009 Purdue MP, Lan Q, Wang SS, Kricker A, Menashe I, Zheng TZ, Hartge P, Grulich AE, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Leaderer BP, Cerhan JR, et al. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis. 30: 275-81. PMID 19029192 DOI: 10.1093/Carcin/Bgn262  0.62
2009 Wang SS, Maurer MJ, Morton LM, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Hartge P, Cerhan JR. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Leukemia. 23: 596-602. PMID 18830263 DOI: 10.1038/Leu.2008.240  0.336
2008 Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, Severson RK, Colt JS, Vasef MA, Rothman N, Blair A, Bernstein L, Cross AJ, De Roos AJ, Engels EA, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood. 112: 5150-60. PMID 18796628 DOI: 10.1182/Blood-2008-01-133587  0.49
2008 Habermann TM, Wang SS, Maurer MJ, Morton LM, Lynch CF, Ansell SM, Hartge P, Severson RK, Rothman N, Davis S, Geyer SM, Cozen W, Chanock SJ, Cerhan JR. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era Blood. 112: 2694-2702. PMID 18633131 DOI: 10.1182/Blood-2007-09-111658  0.43
2008 Cerhan JR, Engels EA, Cozen W, Davis S, Severson RK, Morton LM, Gridley G, Hartge P, Linet M. Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. International Journal of Cancer. Journal International Du Cancer. 123: 888-94. PMID 18506687 DOI: 10.1002/Ijc.23561  0.419
2008 Frankenfeld CL, Cerhan JR, Cozen W, Davis S, Schenk M, Morton LM, Hartge P, Ward MH. Dietary flavonoid intake and non-Hodgkin lymphoma risk. The American Journal of Clinical Nutrition. 87: 1439-45. PMID 18469269 DOI: 10.1093/Ajcn/87.5.1439  0.363
2008 Zhang Y, Sanjose SD, Bracci PM, Morton LM, Wang R, Brennan P, Hartge P, Boffetta P, Becker N, Maynadie M, Foretova L, Cocco P, Staines A, Holford T, Holly EA, et al. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. American Journal of Epidemiology. 167: 1321-31. PMID 18408225 DOI: 10.1093/Aje/Kwn058  0.631
2008 de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, Grulich AE, Cerhan JR, Hartge P, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 6: 451-8. PMID 18387498 DOI: 10.1016/J.Cgh.2008.02.011  0.604
2008 Willett EV, Morton LM, Hartge P, Becker N, Bernstein L, Boffetta P, Bracci P, Cerhan J, Chiu BC, Cocco P, Dal Maso L, Davis S, De Sanjose S, Smedby KE, Ennas MG, et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. International Journal of Cancer. Journal International Du Cancer. 122: 2062-70. PMID 18167059 DOI: 10.1002/Ijc.23344  0.364
2008 Anderson LA, Gridley G, Engels EA, Morton LM, Cerhan JR, Cozen W, Severson RK, Davis S, Hartge P, Linet MS. Antibiotic use and risk of non-Hodgkin's lymphoma: A population-based case-control study British Journal of Cancer. 98: 161-164. PMID 18059393 DOI: 10.1038/Sj.Bjc.6604127  0.391
2008 Shen M, Cozen W, Huang L, Colt J, De Roos AJ, Severson RK, Cerhan JR, Bernstein L, Morton LM, Pickle L, Ward MH. Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma. American Journal of Epidemiology. 167: 350-61. PMID 17989060 DOI: 10.1093/Aje/Kwm292  0.379
2008 Landgren AM, Linet MS, Gridley G, Dores GM, Landgren O, Morton LM. Patterns of autoimmunity and subsequent solid tumors among 4.5 million U.S. veterans Journal of Clinical Oncology. 26: 11020-11020. DOI: 10.1200/Jco.2008.26.15_Suppl.11020  0.376
2007 Morton LM, Landgren O, Chatterjee N, Castenson D, Parsons R, Hoover RN, Engels EA. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood. 110: 4599-605. PMID 17855632 DOI: 10.1182/Blood-2007-07-101956  0.314
2007 Lim U, Morton LM, Subar AF, Baris D, Stolzenberg-Solomon R, Leitzmann M, Kipnis V, Mouw T, Carroll L, Schatzkin A, Hartge P. Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. American Journal of Epidemiology. 166: 697-708. PMID 17596266 DOI: 10.1093/Aje/Kwm122  0.439
2007 Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, Engels EA, Davis S, Severson RK, Rothman N, Chanock SJ, Hartge P. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Research. 67: 5042-54. PMID 17510437 DOI: 10.1158/0008-5472.Can-06-4752  0.404
2007 Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 110: 695-708. PMID 17389762 DOI: 10.1182/Blood-2006-11-051672  0.486
2007 Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Wacholder S, Chanock SJ, Habermann TM, Hartge P. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival Blood. 109: 5439-5446. PMID 17327408 DOI: 10.1182/Blood-2006-11-058040  0.418
2007 Habermann TM, Maurer MJ, Wang SS, Morton LM, Lynch CF, Hartge P, Cozen W, Severson RK, Scott D, Watson DA, Chanock SJ, Rothman N, Cerhan JR. Host Genetic Variation in the Cell Cycle and NF-κB Pathways and Overall Survival in Mantle Cell Lymphoma. Blood. 110: 1582-1582. DOI: 10.1182/Blood.V110.11.1582.1582  0.378
2007 Cerhan JR, Maurer MJ, Hartge P, Chanock SJ, Habermann TM, Cozen W, Davis S, Lynch CF, Severson RK, Rothman N, Morton LM, Wang SS. Polymorphisms in One-Carbon Metabolism Genes and Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 110: 1568-1568. DOI: 10.1182/Blood.V110.11.1568.1568  0.443
2006 Lim U, Subar AF, Mouw T, Hartge P, Morton LM, Stolzenberg-Solomon R, Campbell D, Hollenbeck AR, Schatzkin A. Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1654-9. PMID 16985027 DOI: 10.1158/1055-9965.Epi-06-0203  0.317
2006 Morton LM, Schenk M, Hein DW, Davis S, Zahm SH, Cozen W, Cerhan JR, Hartge P, Welch R, Chanock SJ, Rothman N, Wang SS. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Pharmacogenetics and Genomics. 16: 537-45. PMID 16847422 DOI: 10.1097/01.Fpc.0000215071.59836.29  0.451
2006 Clarke CA, Undurraga DM, Harasty PJ, Glaser SL, Morton LM, Holly EA. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 630-8. PMID 16614102 DOI: 10.1158/1055-9965.Epi-05-0549  0.312
2006 Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Chanock S, Habermann TM, Hartge P. Cytokine Gene Polymorphisms and Overall Survival in Follicular Lymphoma: Results from a Large Population-Based Study. Blood. 108: 820-820. DOI: 10.1182/Blood.V108.11.820.820  0.441
2006 Geyer SM, Morton LM, Habermann TM, Allmer C, Davis S, Cozen W, Severson RK, Lynch CF, Wang S, Maurer MJ, Hartge P, Cerhan JR. Smoking, Obesity and Overall Survival in Non-Hodgkin Lymphoma (NHL): A Population-Based Study. Blood. 108: 4649-4649. DOI: 10.1182/Blood.V108.11.4649.4649  0.319
2006 Thompson CA, Wang S, Maurer MJ, Habermann TM, Severson RK, Rothman N, Lynch CF, Davis S, Morton LM, Cozen W, Hartge P, Geyer SM, Chanock S, Cerhan JR. Host Immunogenetic Single Nucleotide Polymorphisms (SNPs) Predict Overall Survival in Small Lymphocytic Lymphoma. Blood. 108: 2396-2396. DOI: 10.1182/Blood.V108.11.2396.2396  0.448
2006 Habermann TM, Wang S, Maurer MJ, Morton LM, Lynch CF, Ansell SM, Hartge P, Severson RK, Rothman N, Davis S, Geyer SM, Cozen W, Chanock S, Cerhan JR. Germline Single Nucleotide Polymorphisms (SNPs) in IL1A, IL6, IL10, and IFNGR2 in Combination with Clinical with Demographic Factors Predict Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 108: 2028-2028. DOI: 10.1182/Blood.V108.11.2028.2028  0.426
2006 Lim U, Morton LM, Subar AF, Stolzenberg-Solomon R, Bans D, Leitzmann M, Kipnis V, Mouw T, Carroll L, Schatzkin A, Hartge P. Alcohol Intake and Risk of Non-Hodgkin Lymphomas in the Prospective Nih-Aarp Diet and Health Study American Journal of Epidemiology. 163: S89-S89. DOI: 10.1093/Aje/163.Suppl_11.S89-A  0.323
2005 Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, Costantini AS, Stagnaro E, Willett EV, Dal Maso L, Serraino D, Chang ET, Cozen W, Davis S, Severson RK, Bernstein L, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. The Lancet. Oncology. 6: 469-76. PMID 15992695 DOI: 10.1016/S1470-2045(05)70214-X  0.516
2005 Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, Stagnaro E, Willett EV, Franceschi S, La Vecchia C, Hughes AM, Cozen W, Davis S, Severson RK, Bernstein L, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 925-33. PMID 15824165 DOI: 10.1158/1055-9965.Epi-04-0693  0.554
2004 Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang B, Zou K, Morton LM, Owens PH, Flynn S, Tallini G, Zheng T. Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women. American Journal of Epidemiology. 160: 766-73. PMID 15466499 DOI: 10.1093/Aje/Kwh278  0.603
2004 Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Owens PH, Morton LM, Zhang B, Zou K, Flynn S, Tallini G, Zheng T. Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women. American Journal of Epidemiology. 160: 325-30. PMID 15286017 DOI: 10.1093/Aje/Kwh233  0.582
2004 Zheng T, Zhang Y, Morton L, Zhu Y. Re: No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands). Cancer Causes & Control. 15: 433-434. PMID 15248307 DOI: 10.1023/B:Caco.0000027551.90202.5A  0.582
2004 Zhang Y, Holford TR, Leaderer B, Zahm SH, Boyle P, Morton LM, Zhang B, Zou K, Flynn S, Tallini G, Owens PH, Zheng T. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes & Control : Ccc. 15: 419-28. PMID 15141141 DOI: 10.1023/B:Caco.0000027506.55846.5D  0.53
2004 Morton LM, Engels EA, Holford TR, Leaderer B, Zhang Y, Zahm SH, Boyle P, Zhang B, Flynn S, Tallini G, Owens PH, Zheng T. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 425-30. PMID 15006919  0.512
2003 Morton LM, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang Y, Flynn S, Tallini G, Zhang B, Owens PH, Zheng T. Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. British Journal of Cancer. 89: 2087-92. PMID 14647142 DOI: 10.1038/Sj.Bjc.6601388  0.451
2003 Morton LM, Holford TR, Leaderer B, Zhang Y, Zahm SH, Boyle P, Flynn S, Tallini G, Owens PH, Zhang B, Zheng T. Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States). Cancer Causes & Control : Ccc. 14: 687-94. PMID 14575367 DOI: 10.1023/A:1025626208861  0.538
Low-probability matches (unlikely to be authored by this person)
2021 Schonfeld SJ, Kleinerman RA, Abramson DH, Seddon JM, Tucker MA, Morton LM. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors. British Journal of Cancer. PMID 33473166 DOI: 10.1038/s41416-020-01248-y  0.299
2018 Bolton K, Ptashkin R, Braunstein L, Kelly D, Devlin SM, Coombs CC, Moarii M, Patel M, Bernard E, Berthon A, Glodzik D, Walsh MF, Mandelker D, Patel A, Schulman J, ... ... Morton LM, et al. Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis Blood. 132: 747-747. DOI: 10.1182/Blood-2018-99-119530  0.298
2019 Schonfeld SJ, Howell RM, Smith SA, Neglia JP, Turcotte LM, Arnold MA, Inskip PD, Oeffinger KC, Moskowitz CS, Henderson TO, Leisenring WM, Gibson TM, de González AB, Sampson JN, Chanock SJ, ... ... Morton LM, et al. Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Radiation Research. PMID 31794291 DOI: 10.1667/Rr15308.1  0.297
2020 Dores GM, Curtis RE, Dalal NH, Linet MS, Morton LM. Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2000264. PMID 32946352 DOI: 10.1200/Jco.20.00264  0.296
2016 Howlader N, Morton LM, Feuer EJ, Besson C, Engels EA. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 174-9. PMID 26472423 DOI: 10.1158/1055-9965.Epi-15-0921  0.295
2021 Besson C, Moore A, Wu W, Vajdic CM, de Sanjose S, Camp NJ, Smedby KE, Shanafelt TD, Morton LM, Brewer JD, Zablotska L, Engels EA, Cerhan JR, Slager SL, Han J, et al. Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer. International Journal of Epidemiology. PMID 33748835 DOI: 10.1093/ije/dyab042  0.295
2010 Quinlan SC, Morton LM, Pfeiffer RM, Anderson LA, Landgren O, Warren JL, Engels EA. Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1229-37. PMID 20406959 DOI: 10.1158/1055-9965.Epi-09-1220  0.294
2012 Berrington de González A, Morton LM. Converting epidemiologic studies of cancer etiology to survivorship studies: approaches and challenges. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 875-80. PMID 22426143 DOI: 10.1158/1055-9965.Epi-12-0131  0.294
2018 Morton LM, Dores GM, Schonfeld SJ, Linet MS, Sigel BS, Lam CJK, Tucker MA, Curtis RE. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era. Jama Oncology. PMID 30570657 DOI: 10.1001/Jamaoncol.2018.5625  0.293
2020 Hawkins M, Bhatia S, Henderson TO, Nathan PC, Yan A, Teepen JC, Morton LM. Subsequent Primary Neoplasms: Risks, Risk Factors, Surveillance, and Future Research. Pediatric Clinics of North America. 67: 1135-1154. PMID 33131538 DOI: 10.1016/j.pcl.2020.07.006  0.289
2016 Rothman N, Bassig BA, Au W, Mang O, Ngan R, Morton LM, Ip DKM, Hu W, Zheng T, Seow WJ, Xu J, Lan Q. Abstract 5207: Comparison of subtype-specific incidence rates of lymphoid malignancies in Hong Kong and the United States Cancer Research. 76: 5207-5207. DOI: 10.1158/1538-7445.Am2016-5207  0.289
2017 Engels EA, Parsons R, Besson C, Morton LM, Yanik EL, Arem H, Pfeiffer RM. RE: The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study. Journal of the National Cancer Institute. 109. PMID 28423403 DOI: 10.1093/Jnci/Djx026  0.289
2014 Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT. The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. e57-67. PMID 24857148 DOI: 10.14694/EdBook_AM.2014.34.e57  0.289
2019 Mahale P, Engels EA, Lynch CF, Morton LM. Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients. British Journal of Haematology. PMID 30820931 DOI: 10.1111/Bjh.15828  0.285
2017 Berrington de Gonzalez A, Journy N, Lee C, Morton LM, Harbron R, Stewart DR, Parker L, Craft AW, McHugh K, Little M, Pearce M. No association between radiation dose from pediatric CT scans and risk of subsequent Hodgkin lymphoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28052939 DOI: 10.1158/1055-9965.Epi-16-1011  0.285
2013 Lamart S, Stovall M, Simon SL, Smith SA, Weathers RE, Howell RM, Curtis RE, Aleman BM, Travis L, Kwon D, Morton LM. Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients. International Journal of Radiation Oncology, Biology, Physics. 86: 694-701. PMID 23628135 DOI: 10.1016/J.Ijrobp.2013.03.014  0.285
2011 Quinlan SC, Pfeiffer RM, Morton LM, Engels EA. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. American Journal of Hematology. 86: 206-9. PMID 21264909 DOI: 10.1002/Ajh.21911  0.285
2011 Morton LM, Landgren O. Associations between non-Hodgkin lymphoma and renal cell carcinoma. Leukemia & Lymphoma. 52: 2201-2. PMID 21854083 DOI: 10.3109/10428194.2011.614711  0.283
2021 Pronk A, Nuckols JR, De Roos AJ, Airola M, Colt JS, Cerhan JR, Morton L, Cozen W, Severson R, Blair A, Cleverly D, Ward MH. Correction to: Residential proximity to industrial combustion facilities and risk of non-Hodgkin lymphoma: a case-control study. Environmental Health : a Global Access Science Source. 20: 113. PMID 34719389 DOI: 10.1186/s12940-021-00798-9  0.282
2020 Morton LM. Novel Insights Into the Long-Term Immune Health of Diffuse Large B-Cell Lymphoma Survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2000361. PMID 32228357 DOI: 10.1200/Jco.20.00361  0.282
2014 Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, ... ... Morton LM, et al. Pancreatic cancer risk after treatment of Hodgkin lymphoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 2073-9. PMID 25185241 DOI: 10.1093/annonc/mdu287  0.282
2015 Morton LM, Dores GM, Shiels MS, Linet MS, Teepen JC, Lam CJ, Tucker MA, Curtis RE. Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012 Blood. 126: 562-562. DOI: 10.1182/blood.v126.23.562.562  0.281
2020 Morton LM, Karyadi DM, Hartley SW, Frone MN, Sampson JN, Howell RM, Neglia JP, Arnold MA, Hicks BD, Jones K, Zhu B, Dagnall CL, Karlins E, Yeager MS, Leisenring WM, et al. Subsequent Neoplasm Risk Associated With Rare Variants in DNA Damage Response and Clinical Radiation Sensitivity Syndrome Genes in the Childhood Cancer Survivor Study. Jco Precision Oncology. 4. PMID 32923912 DOI: 10.1200/PO.20.00141  0.281
2014 Smedby KE, Sampson JN, Turner JJ, Slager SL, Maynadié M, Roman E, Habermann TM, Flowers CR, Berndt SI, Bracci PM, Hjalgrim H, Weisenburger DD, Morton LM. Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute. Monographs. 2014: 76-86. PMID 25174028 DOI: 10.1093/jncimonographs/lgu007  0.281
2014 Shiels MS, Koritzinsky EH, Clarke CA, Suneja G, Morton LM, Engels EA. Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 274-81. PMID 24326629 DOI: 10.1158/1055-9965.Epi-13-0865  0.28
2020 Im C, Li N, Moon W, Liu Q, Morton LM, Leisenring WM, Howell RM, Chow EJ, Sklar CA, Wilson CL, Wang Z, Sapkota Y, Chemaitilly W, Ness KK, Hudson MM, et al. Genome-wide association studies reveal novel locus with sex-/therapy-specific fracture risk effects in childhood cancer survivors. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 33338273 DOI: 10.1002/jbmr.4234  0.278
2019 Herr MM, Curtis RE, Tucker MA, Tecca HR, Engels EA, Cahoon EK, Battiwalla M, Buchbinder D, Flowers ME, Brazauskas R, Shaw BE, Morton LM. Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation. Journal of the American Academy of Dermatology. PMID 31654664 DOI: 10.1016/j.jaad.2019.10.034  0.277
2018 Dagnall CL, Morton LM, Hicks BD, Li S, Zhou W, Karlins E, Teshome K, Chowdhury S, Lashley KS, Sampson JN, Robison LL, Armstrong GT, Bhatia S, Radloff GA, Davies SM, et al. Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays. Bmc Genomics. 19: 182. PMID 29510662 DOI: 10.1186/S12864-018-4572-6  0.273
2007 Morton LM, Bernstein L, Wang SS, Hein DW, Rothman N, Colt JS, Davis S, Cerhan JR, Severson RK, Welch R, Hartge P, Zahm SH. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis. 28: 1759-64. PMID 17522066 DOI: 10.1093/carcin/bgm121  0.272
2006 Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. American Journal of Epidemiology. 163: 197-203. PMID 16339049 DOI: 10.1093/Aje/Kwj036  0.269
2021 Song N, Liu Q, Wilson CL, Sapkota Y, Ehrhardt MJ, Gibson TM, Morton LM, Chanock SJ, Neglia JP, Arnold MA, Michael JR, Gout AM, Mulder HL, Easton J, Bhatia S, et al. Polygenic Risk Score Improves Risk Stratification and Prediction of Subsequent Thyroid Cancer after Childhood Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34465587 DOI: 10.1158/1055-9965.EPI-21-0448  0.269
2021 Trendowski MR, Baedke JL, Sapkota Y, Travis LB, Zhang X, El Charif O, Wheeler HE, Leisenring WM, Robison LL, Hudson MM, Morton LM, Oeffinger KC, Howell RM, Armstrong GT, Bhatia S, et al. Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort. Cancer. PMID 34286861 DOI: 10.1002/cncr.33775  0.268
2016 Shiels MS, Pfeiffer RM, Besson C, Clarke CA, Morton LM, Nogueira L, Pawlish K, Yanik EL, Suneja G, Engels EA. Trends in primary central nervous system lymphoma incidence and survival in the U.S. British Journal of Haematology. PMID 27018254 DOI: 10.1111/Bjh.14073  0.266
2013 Lamart S, Imran R, Simon SL, Doi K, Morton LM, Curtis RE, Lee C, Drozdovitch V, Maass-Moreno R, Chen CC, Whatley M, Miller DL, Pacak K, Lee C. Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy. Physics in Medicine and Biology. 58: 8739-53. PMID 24301086 DOI: 10.1088/0031-9155/58/24/8739  0.262
2014 Morton LM, Swerdlow AJ, Schaapveld M, Ramadan S, Hodgson DC, Radford J, van Leeuwen FE. Current knowledge and future research directions in treatment-related second primary malignancies. Ejc Supplements : Ejc : Official Journal of Eortc, European Organization For Research and Treatment of Cancer ... [Et Al.]. 12: 5-17. PMID 26217162 DOI: 10.1016/j.ejcsup.2014.05.001  0.261
2022 Pasqual E, Schonfeld S, Morton LM, Villoing D, Lee C, Berrington de Gonzalez A, Kitahara CM. Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101841. PMID 35044839 DOI: 10.1200/JCO.21.01841  0.261
2017 Lee C, Morton LM, de Gonzalez AB. A NOVEL METHOD TO ESTIMATE LYMPHOCYTE DOSE AND APPLICATION TO PEDIATRIC AND YOUNG ADULT CT PATIENTS IN THE UNITED KINGDOM. Radiation Protection Dosimetry. 1-6. PMID 28981878 DOI: 10.1093/Rpd/Ncx084  0.259
2012 Shiels MS, Engels EA, Clarke C, Hall HI, Hartge P, Li J, Linet MS, Morton LM. Abstract 5501: The non-Hodgkin lymphoma epidemic in the United States: Recent trends in the absence of HIV-related cases Cancer Research. 72: 5501-5501. DOI: 10.1158/1538-7445.Am2012-5501  0.259
2024 Tran TV, Schonfeld SJ, Pasqual E, Haymart MR, Morton LM, Kitahara CM. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States. Thyroid : Official Journal of the American Thyroid Association. PMID 38149602 DOI: 10.1089/thy.2023.0449  0.256
2020 Morton LM. Testicular Cancer as a Model for Understanding the Impact of Evolving Treatment Strategies on the Long-Term Health of Cancer Survivors. Jnci Cancer Spectrum. 4: pkaa013. PMID 32455333 DOI: 10.1093/Jncics/Pkaa013  0.256
2014 Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD, Dores GM. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. British Journal of Haematology. 165: 67-77. PMID 24417667 DOI: 10.1111/Bjh.12730  0.256
2013 Black A, Pinsky PF, Grubb RL, Daugherty SE, Park Y, Morton LM, Hoover RN, Berrington de Gonzaĺez A. 333 SECOND CANCERS FOLLOWING RADIOTHERAPY IN PROSTATE CANCER PATIENTS IN THE PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1719  0.252
2018 Morton LM, Kerns SL, Dolan ME. Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 775-786. PMID 30231410 DOI: 10.1200/EDBK_201391  0.252
2016 Journy NM, Morton LM, Kleinerman RA, Bekelman JE, Berrington de Gonzalez A. Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer. Jama Oncology. PMID 27415446 DOI: 10.1001/Jamaoncol.2016.1368  0.252
2017 Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, ... ... Morton LM, et al. Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects. Radiation Research. PMID 28118119 DOI: 10.1667/RR14453.1  0.25
2012 Kim CJ, Cozen W, Weiss LM, Bhatia K, Cockburn M, Hawes D, Wang SS, Engels EA, Morton LM. Abstract 4490: Molecular characteristics of diffuse large B-cell lymphoma in HIV-positive and HIV-negative patients Epidemiology. 72: 4490-4490. DOI: 10.1158/1538-7445.Am2012-4490  0.248
2008 Zahm SH, Morton LM, Bernstein L, Wang SS, Colt JS, Severson RK, Welch R, Hartge P. Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response. Carcinogenesis. 29: 1084-5. PMID 18212328 DOI: 10.1093/Carcin/Bgn023  0.248
2011 González ABd, Brenner A, Hartge P, Lee C, Morton L, Rajaraman P. Evolving Strategies in Epidemiologic Research on Radiation and Cancer Radiation Research. 176: 527-532. PMID 21823973 DOI: 10.1667/Rrxx37.1  0.247
2011 Lamart S, Morton L, Simon S, Curtis R, Aleman B, Smith S, Weathers R, Stovall M. Radiation Doses to the Esophagus from Radiotherapy Treatment for Breast Cancer during 1943-2001 International Journal of Radiation Oncology*Biology*Physics. 81: S250. DOI: 10.1016/J.Ijrobp.2011.06.1726  0.244
2021 Sapkota Y, Li N, Pierzynski J, Mulrooney DA, Ness KK, Morton LM, Michael JR, Zhang J, Bhatia S, Armstrong GT, Hudson MM, Robison LL, Yasui Y. Contribution of Polygenic Risk to Hypertension Among Long-Term Survivors of Childhood Cancer. Jacc. Cardiooncology. 3: 76-84. PMID 33842896 DOI: 10.1016/j.jaccao.2021.01.007  0.239
2012 DellaValle C, Wheeler D, De Roos A, Severson R, Cozen W, Cerhan J, Colt J, Morton L, Ward M. P-226 Epidemiology. 23: 1. DOI: 10.1097/01.Ede.0000417229.97224.9B  0.236
2009 Morton LM, Wang SS, Richesson DA, Schatzkin A, Hollenbeck AR, Lacey JV. Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort. International Journal of Cancer. Journal International Du Cancer. 124: 2737-43. PMID 19253366 DOI: 10.1002/ijc.24248  0.231
2021 van Hoefen Wijsard M, Schonfeld SJ, van Leeuwen FE, Moll AC, Fabius AW, Abramson DH, Seddon JM, Francis JH, Tucker MA, Kleinerman RA, Morton LM. Benign Tumors in Long-Term Survivors of Retinoblastoma. Cancers. 13. PMID 33917779 DOI: 10.3390/cancers13081773  0.23
2006 Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 107: 265-76. PMID 16150940 DOI: 10.1182/blood-2005-06-2508  0.229
2018 Morton LM, Ricks-Santi L, West CML, Rosenstein BS. Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy. International Journal of Particle Therapy. 5: 103-113. PMID 30505881 DOI: 10.14338/IJPT-18-00009.1  0.228
2022 Richard MA, Mostoufi-Moab S, Rathore N, Baedke J, Brown AL, Chanock SJ, Friedman DN, Gramatges MM, Howell RM, Kamdar KY, Leisenring WM, Meacham LR, Morton LM, Oeffinger K, Robison LL, et al. Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. Jco Precision Oncology. 6: e2200239. PMID 36480781 DOI: 10.1200/PO.22.00239  0.226
2019 Kleinerman RA, Tucker MA, Sigel BS, Abramson DH, Seddon JM, Morton LM. Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914-2016. Journal of the National Cancer Institute. PMID 30698734 DOI: 10.1093/Jnci/Djy227  0.222
2021 Kleinerman RA, Schonfeld SJ, Abramson DH, Francis JH, Seddon JM, Morton LM, Tucker MA. Increased risk of skin cancer in 1851 long-term retinoblastoma survivors. The Journal of Investigative Dermatology. PMID 34153328 DOI: 10.1016/j.jid.2021.05.021  0.217
2007 Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P, Hayes RB, Chanock SJ, Caporaso NE. Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Human Genetics. 122: 41-9. PMID 17497175 DOI: 10.1007/s00439-007-0374-7  0.217
2017 Withrow DR, Berrington de Gonzalez A, Linet MS, Morton LM, Lam CJ, Shiels MS. Trends in Malignant Brain and Central Nervous System Tumor Incidence by Subtype Among Children in the United States, 1998-2013 Annals of Epidemiology. 27: 505. DOI: 10.1016/J.Annepidem.2017.07.032  0.216
2023 Steidl C, Kridel R, Binkley M, Morton LM, Chadburn A. The pathobiology of select adolescent young adult lymphomas. Ejhaem. 4: 892-901. PMID 38024596 DOI: 10.1002/jha2.785  0.214
2014 Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, Tomotaka S, Morton LM, Weisenburger DD, Matsuo K. Differences in incidence and trends of haematological malignancies in Japan and the United States. British Journal of Haematology. 164: 536-45. PMID 24245986 DOI: 10.1111/bjh.12659  0.213
2021 Advani PG, Morton LM, Kitahara CM, de Gonzalez AB, Ramin C, Haymart MR, Curtis RE, Schonfeld SJ. Assessment of surveillance versus etiologic factors in the reciprocal association between papillary thyroid cancer and breast cancer. Cancer Epidemiology. 74: 101985. PMID 34280845 DOI: 10.1016/j.canep.2021.101985  0.213
2019 Colli LM, Morton LM, Chanock SJ. Sex-related effect on immunotherapy response: implications and opportunities. Journal of the National Cancer Institute. PMID 31106816 DOI: 10.1093/Jnci/Djz096  0.212
2011 Wheeler DC, De Roos AJ, Cerhan JR, Morton LM, Severson R, Cozen W, Ward MH. Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study. Environmental Health : a Global Access Science Source. 10: 63. PMID 21718483 DOI: 10.1186/1476-069X-10-63  0.212
2023 Kim J, Karyadi DM, Hartley SW, Zhu B, Wang M, Wu D, Song L, Armstrong GT, Bhatia S, Robison LL, Yasui Y, Carter B, Sampson JN, Freedman ND, Goldstein AM, ... ... Morton LM, et al. Inflated expectations: Rare-variant association analysis using public controls. Plos One. 18: e0280951. PMID 36696392 DOI: 10.1371/journal.pone.0280951  0.212
2021 Chihara D, Larson MC, Robinson DP, Thompson CA, Maurer MJ, Casulo C, Pophali P, Link BK, Habermann TM, Feldman AL, Flowers CR, Cerhan JR, Morton LM. Body mass index and survival of patients with lymphoma. Leukemia & Lymphoma. 1-8. PMID 34121594 DOI: 10.1080/10428194.2021.1929956  0.211
2019 Dores GM, Curtis RE, Dalal NH, Linet MS, Morton LM. Population-Based, Cause-Specific Risk of Non-Lymphoma Deaths Among 20,491 Adults with Classical Hodgkin Lymphoma (cHL) Treated with Initial Chemotherapy in the United States, 2000-2015 Blood. 134: 4034-4034. DOI: 10.1182/blood-2019-124831  0.209
2005 Chen J, Wacholder S, Morton LM, Bhatti P, Hartge P. 577: Quantifying Selection Bias in Epidemiologic Studies American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S145  0.209
2017 Hodgson D, van Leeuwen F, Ng A, Morton L, Henderson TO. Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It's Not Just About Chest Radiation. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Meeting. 37: 736-745. PMID 28561716 DOI: 10.1200/EDBK_175668  0.208
2020 Bolton KL, Ptashkin RN, Gao T, Braunstein L, Devlin SM, Patel M, Berthon A, Syed A, Yabe M, Coombs C, Caltabellotta NM, Walsh M, Offit K, Stadler Z, Lee C, ... ... Morton L, et al. Abstract 5703: Oncologic therapy shapes the fitness landscape of clonal hematopoiesis Tumor Biology. DOI: 10.1158/1538-7445.Am2020-5703  0.204
2020 Dixon SB, Chow EJ, Hjorth L, Hudson MM, Kremer LCM, Morton LM, Nathan PC, Ness KK, Oeffinger KC, Armstrong GT. The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress. Pediatric Clinics of North America. 67: 1237-1251. PMID 33131544 DOI: 10.1016/j.pcl.2020.07.013  0.203
2011 Morton LM, Cerhan JR, Hartge P, Vasef MA, Neppalli VT, Natkunam Y, Dogan A, Dave BJ, Jain S, Levy R, Lossos IS, Cozen W, Davis S, Schenk MJ, Maurer MJ, et al. Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. International Journal of Molecular Epidemiology and Genetics. 2: 245-52. PMID 21915363  0.198
2022 Sapkota Y, Ehrhardt MJ, Qin N, Wang Z, Liu Q, Qiu W, Shelton K, Shao Y, Plyler E, Mulder HL, Easton J, Michael JR, Burridge PW, Wang X, Wilson CL, ... ... Morton LM, et al. A novel locus on 6p21.2 for cancer treatment-induced cardiac dysfunction among childhood cancer survivors. Journal of the National Cancer Institute. PMID 35698272 DOI: 10.1093/jnci/djac115  0.197
2023 Morton LM, Curtis RE, Linet MS, Schonfeld SJ, Advani PG, Dalal NH, Sasse EC, Dores GM. Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000-2018. Eclinicalmedicine. 61: 102060. PMID 37457112 DOI: 10.1016/j.eclinm.2023.102060  0.194
2020 Tonorezos ES, Friedman DN, Barnea D, Bosscha MI, Chantada G, Dommering CJ, de Graaf P, Dunkel IJ, Fabius AWM, Francis JH, Greer MC, Kleinerman RA, Kors WA, Laughlin S, Moll AC, ... Morton LM, et al. Recommendations for long-term follow-up of adults with heritable retinoblastoma. Ophthalmology. PMID 32422154 DOI: 10.1016/J.Ophtha.2020.05.024  0.193
2012 Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, et al. Risk of treatment-related esophageal cancer among breast cancer survivors. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 3081-91. PMID 22745217 DOI: 10.1093/annonc/mds144  0.192
2014 Morton LM, Gibson TM, Clarke CA, Lynch CF, Weisenburger DD, Engels EA. Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients. Haematologica. 99: 70-3. PMID 24561790 DOI: 10.3324/haematol.2013.101600  0.192
2011 Morton LM, Clarke CA, Chang ET, Hall EC, Lynch CF, Pfieffer R, Weisenburger DD, Engels EA. Risk of Acute Myeloid Leukemia Among Solid Organ Transplant Recipients Blood. 118: 2559-2559. DOI: 10.1182/blood.V118.21.2559.2559  0.191
2021 Kim J, Gianferante M, Karyadi DM, Hartley SW, Frone MN, Luo W, Robison LL, Armstrong GT, Bhatia S, Dean M, Yeager M, Zhu B, Song L, Sampson JN, Yasui Y, ... ... Morton LM, et al. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study. Jnci Cancer Spectrum. 5: pkab007. PMID 34308104 DOI: 10.1093/jncics/pkab007  0.19
2020 Richard MA, Brown AL, Belmont JW, Scheurer ME, Arroyo VM, Foster KL, Kern KD, Hudson MM, Leisenring WM, Okcu MF, Sapkota Y, Yasui Y, Morton LM, Chanock SJ, Robison LL, et al. Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort. Cancer. PMID 33048379 DOI: 10.1002/cncr.33258  0.189
2020 Morton LM, Hamilton BK. Using patient-reported outcomes to improve survivorship care. Blood. 135: 1819-1820. PMID 32437561 DOI: 10.1182/Blood.2020005881  0.187
2023 Lee OW, Rodrigues C, Lin SH, Luo W, Jones K, Brown DW, Zhou W, Karlins E, Khan SM, Baulande S, Raynal V, Surdez D, Reynaud S, Rubio RA, Zaidi S, ... ... Morton LM, et al. Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding. American Journal of Human Genetics. PMID 36787739 DOI: 10.1016/j.ajhg.2023.01.017  0.181
2023 Pithadia KJ, Advani PG, Citrin DE, Bekelman JE, Withrow DR, Berrington de Gonzalez A, Morton LM, Schonfeld SJ. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015. Jama Oncology. PMID 37289449 DOI: 10.1001/jamaoncol.2023.1638  0.18
2022 Henderson TO, Liu Q, Turcotte LM, Neglia JP, Leisenring W, Hodgson D, Diller L, Kenney L, Morton L, Berrington de Gonzalez A, Arnold M, Bhatia S, Howell RM, Smith SA, Robison LL, et al. Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study (CCSS). Jama Oncology. PMID 36227603 DOI: 10.1001/jamaoncol.2022.4649  0.177
2022 Dores GM, Linet MS, Curtis RE, Morton LM. Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia. Blood. PMID 36379026 DOI: 10.1182/blood.2022018051  0.177
2017 Agrawal S, Moser KA, Morton L, Cummings MP, Parihar A, Dwivedi A, Shetty AC, Drabek EF, Jacob CG, Henrich PP, Parobek CM, Jongsakul K, Huy R, Spring MD, Lanteri CA, et al. Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity. The Journal of Infectious Diseases. 216: 468-476. PMID 28931241 DOI: 10.1093/Infdis/Jix334  0.173
2022 Bassig BA, Hu W, Morton LM, Ji BT, Xu J, Linet MS, Kwong YL, Rothman N, Wong KF, Lan Q. Incidence of myeloid malignancies by subtype in Hong Kong and comparisons with Asian and white men and women in the United States. Leukemia & Lymphoma. 1-8. PMID 35412943 DOI: 10.1080/10428194.2022.2045593  0.173
2013 Linet MS, Dores GM, Kim CJ, Devesa SS, Morton LM. Epidemiology and hereditary aspects of acute leukemia Neoplastic Diseases of the Blood. 199-212. DOI: 10.1007/978-1-4614-3764-2_15  0.172
2022 Rigter LS, Snaebjornsson P, Rosenberg EH, Altena E, van Grieken NCT, Aleman BMP, Kerst JM, Morton L, Schaapveld M, Meijer GA, van Leeuwen FE, van Leerdam ME. Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer. Plos One. 17: e0270591. PMID 35877698 DOI: 10.1371/journal.pone.0270591  0.167
2013 Shiels MS, Engels EA, Linet MS, Clarke CA, Li J, Hall HI, Hartge P, Morton LM. The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1069-78. PMID 23595542 DOI: 10.1158/1055-9965.Epi-13-0040  0.162
2013 Kleinerman RA, Smith SA, Holowaty E, Hall P, Pukkala E, Vaalavirta L, Stovall M, Weathers R, Gilbert E, Aleman BM, Kaijser M, Andersson M, Storm H, Joensuu H, Lynch CF, ... ... Morton LM, et al. Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 86: 922-9. PMID 23707149 DOI: 10.1016/j.ijrobp.2013.04.010  0.16
2021 Schaar DA, Pirsl F, Holtzman N, Steinberg SM, Nashed J, Ruben C, Cowen EW, Mays JW, Mitchell S, Ostojic A, Munshi PN, Joe GO, Comis LE, Morton L, Pavletic SZ. Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy. PMID 34380090 DOI: 10.1016/j.jtct.2021.08.001  0.156
2014 Morton LM, Kim CJ, Weiss LM, Bhatia K, Cockburn M, Hawes D, Wang SS, Chang C, Altekruse SF, Engels EA, Cozen W. Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era. Leukemia & Lymphoma. 55: 551-7. PMID 23772639 DOI: 10.3109/10428194.2013.813499  0.149
2023 Esteghamat NS, Brunson A, Rosenberg AS, Schonfeld SJ, Valcarcel B, Abrahão R, Cooley JJP, Meyer CL, Auletta JJ, Morton LM, Muffly L, Wun T, Keegan THM. Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study. Clinical Lymphoma, Myeloma & Leukemia. PMID 38195324 DOI: 10.1016/j.clml.2023.12.009  0.148
2020 Bolton KL, Ptashkin RN, Gao T, Braunstein L, Devlin SM, Kelly D, Patel M, Berthon A, Syed A, Yabe M, Coombs CC, Caltabellotta NM, Walsh M, Offit K, Stadler Z, ... ... Morton LM, et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nature Genetics. PMID 33106634 DOI: 10.1038/s41588-020-00710-0  0.144
2022 Thanarajasingam G, Minasian LM, Bhatnagar V, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gormley N, Gribben J, Horowitz M, Ivy SP, Jacobson CA, ... ... Morton LM, et al. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies. The Lancet. Haematology. 9: e374-e384. PMID 35483398 DOI: 10.1016/S2352-3026(22)00045-X  0.141
2023 Valcarcel B, Schonfeld SJ, Meyer CL, Brunson A, Cooley JJP, Abrahão R, Wun T, Auletta JJ, Gadalla SM, Engels E, Albert PS, Spellman SR, Rizzo JD, Shaw BE, Muffly L, ... ... Morton LM, et al. Comparison of vital status, cause of death, and follow-up after HCT in linked CIBMTR and California Cancer Registry data, 1991-2018. Transplantation and Cellular Therapy. PMID 37981238 DOI: 10.1016/j.jtct.2023.11.011  0.13
2021 Morton LM, Karyadi DM, Stewart C, Bogdanova TI, Dawson ET, Steinberg MK, Dai J, Hartley SW, Schonfeld SJ, Sampson JN, Maruvka Y, Kapoor V, Ramsden DA, Carvajal-Garcia J, Perou CM, et al. Radiation-related genomic profile of papillary thyroid cancer after the Chernobyl accident. Science (New York, N.Y.). PMID 33888599 DOI: 10.1126/science.abg2538  0.126
2006 Morton LM, Wang SS, Bergen AW, Chatterjee N, Kvale P, Welch R, Yeager M, Hayes RB, Chanock SJ, Caporaso NE. DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenetics and Genomics. 16: 901-10. PMID 17108814 DOI: 10.1097/01.fpc.0000230417.20468.d0  0.123
2024 Linet MS, Curtis RE, Schonfeld SJ, Vo JB, Morton LM, Dores GM. Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001-2019. Eclinicalmedicine. 71: 102549. PMID 38524920 DOI: 10.1016/j.eclinm.2024.102549  0.12
2015 Grünewald TGP, Bernard V, Gilardi-Hebenstreit P, Raynal V, Surdez D, Aynaud MM, Mirabeau O, Cidre-Aranaz F, Tirode F, Zaidi S, Perot G, Jonker AH, Lucchesi C, Le Deley MC, Oberlin O, ... ... Morton LM, et al. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite Nature Genetics. DOI: 10.1038/ng.3363  0.117
2022 Keegan THM, Brunson A, Cooley JJP, Schonfeld SJ, Meyer CL, Valcarcel B, Abrahao R, Wun T, Auletta J, Muffly L, Morton LM. Linking the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry to the California Cancer Registry and California Hospital Patient Discharge Data. Transplantation and Cellular Therapy. PMID 36174935 DOI: 10.1016/j.jtct.2022.09.016  0.114
2009 Azzato EM, Morton LM, Bergen AW, Wang SS, Chatterjee N, Kvale P, Yeager M, Hayes RB, Chanock SJ, Caporaso NE. SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Bmc Medical Genetics. 10: 9. PMID 19183461 DOI: 10.1186/1471-2350-10-9  0.112
2013 Morton LM. Dissecting lymphoma incidence to inform epidemiologic and clinical research. Leukemia & Lymphoma. 54: 1575-6. PMID 23391143 DOI: 10.3109/10428194.2013.774000  0.109
2007 Lim U, Hartge P, Morton LM, Schatzkin A. Aspartame consumption and incidence of hematopoietic and brain cancers [6] Cancer Epidemiology Biomarkers and Prevention. 16: 1528-1529. DOI: 10.1158/1055-9965.EPI-07-0492  0.105
2022 Morton L, Forshey B, Bishop-Lilly K, Cer R, Fries A, Bogue A, Undewood R, Bazaco S, Starr C, Gruner W, Malagon F, Myers C, Maljkovic Berry I, Kugelman J, Creppage K, et al. Establishment of SARS-CoV-2 genomic surveillance within the Military Health System during 1 March-31 December 2020. Msmr. 29: 11-18. PMID 36250580  0.105
2008 Carreon JD, Morton LM, Devesa SS, Clarke CA, Gomez SL, Glaser SL, Sakoda LC, Linet MS, Wang SS. Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004. Cancer Causes & Control : Ccc. 19: 1171-81. PMID 18543071 DOI: 10.1007/S10552-008-9184-Z  0.094
2015 Plucinski MM, Morton L, Bushman M, Dimbu PR, Udhayakumar V. Robust Algorithm for Systematic Classification of Malaria Late Treatment Failures as Recrudescence or Reinfection Using Microsatellite Genotyping. Antimicrobial Agents and Chemotherapy. 59: 6096-100. PMID 26195521 DOI: 10.1128/AAC.00072-15  0.093
2023 Pophali PA, Morton LM, Parsons SK, Hodgson D, Thanarajasingam G, Thompson C, Habermann TM, Savage KJ. Critical gaps in understanding treatment outcomes in adolescents and young adults with lymphoma: A review of current data. Ejhaem. 4: 927-933. PMID 38024619 DOI: 10.1002/jha2.778  0.093
2020 Maljkovic Berry I, Rutvisuttinunt W, Voegtly LJ, Prieto K, Pollett S, Cer RZ, Kugelman JR, Bishop-Lilly KA, Morton L, Waitumbi J, Jarman RG. A Department of Defense Laboratory Consortium Approach to Next Generation Sequencing and Bioinformatics Training for Infectious Disease Surveillance in Kenya. Frontiers in Genetics. 11: 577563. PMID 33101395 DOI: 10.3389/fgene.2020.577563  0.09
2022 Schonfeld SJ, Tucker MA, Engels EA, Dores GM, Sampson JN, Shiels MS, Chanock SJ, Morton LM. Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults. Jama Network Open. 5: e223461. PMID 35315916 DOI: 10.1001/jamanetworkopen.2022.3461  0.088
2012 Morton LM. Smoking and lymphoma: a small part of a complex story. Leukemia & Lymphoma. 53: 1853-4. PMID 22462617 DOI: 10.3109/10428194.2012.680454  0.088
2013 Morton LM, Bolton LL, Corbett LQ, Girolami S, Phillips TJ. An evaluation of the association for the advancement of wound care venous ulcer guideline and recommendations for further research. Advances in Skin & Wound Care. 26: 553-61. PMID 24253212 DOI: 10.1097/01.ASW.0000434057.81199.6c  0.086
2017 Mitchell BG, Petrie D, Morton L, Dancer SJ. What's Trending in Infection Control? Scoping and Narrative Reviews. Infection Control and Hospital Epidemiology. 1-5. PMID 28693642 DOI: 10.1017/ice.2017.130  0.086
2015 Talundzic E, Okoth SA, Congpuong K, Plucinski MM, Morton L, Goldman IF, Kachur PS, Wongsrichanalai C, Satimai W, Barnwell JW, Udhayakumar V. Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. Plos Pathogens. 11: e1004789. PMID 25836766 DOI: 10.1371/journal.ppat.1004789  0.077
2015 Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, Goldman I, Lucchi N, Stennies G, MacArthur JR, Udhayakumar V. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola. Antimicrobial Agents and Chemotherapy. 59: 437-43. PMID 25367912 DOI: 10.1128/AAC.04181-14  0.075
2021 Dores GM, Curtis RE, Linet MS, Morton LM. Cause-specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the U.S. population, 2001-2017. American Journal of Hematology. PMID 34559904 DOI: 10.1002/ajh.26362  0.073
2019 Maljkovic Berry I, Melendrez MC, Bishop-Lilly KA, Rutvisuttinunt W, Pollett S, Talundzic E, Morton L, Jarman RG. Next Generation Sequencing and Bioinformatics Methodologies for Infectious Disease Research and Public Health: Approaches, Applications, and Considerations for Development of Laboratory Capacity. The Journal of Infectious Diseases. PMID 31612214 DOI: 10.1093/infdis/jiz286  0.07
2024 Wardenaar FC, Lybbert H, Morton L, Schott KD, Shumate C, Levinson S, Wharton C, Kulinna P, van der Mars H. High School Athletes' Use and Knowledge of (Safe) Nutritional Supplement Use: An Exploratory Study. Journal of Dietary Supplements. 1-17. PMID 38230707 DOI: 10.1080/19390211.2023.2301361  0.069
2013 Morton LM, Phillips TJ. Venous eczema and lipodermatosclerosis. Seminars in Cutaneous Medicine and Surgery. 32: 169-76. PMID 24175404  0.063
2015 Morton LM, Dover JS, Phillips TJ, Krakowski AC, Uebelhoer NS. Treatment of ulcers with ablative fractional lasers. Seminars in Cutaneous Medicine and Surgery. 34: 37-41. PMID 25922956 DOI: 10.12788/j.sder.2015.0128  0.052
2013 Morton LM, Smith KC, Dover JS, Arndt KA. Treatment of purpura with lasers and light sources Journal of Drugs in Dermatology. 12: 1219-1222. PMID 24196329  0.051
2015 Talundzic E, Okoth SA, Congpuong K, Plucinski MM, Morton L, Goldman IF, Kachur PS, Wongsrichanalai C, Satimai W, Barnwell JW, Udhayakumar V. Correction: selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. Plos Pathogens. 11: e1004862. PMID 25901903 DOI: 10.1371/journal.ppat.1004862  0.045
2016 Morton LM, Phillips TJ. Wound healing and treating wounds: Differential diagnosis and evaluation of chronic wounds. Journal of the American Academy of Dermatology. 74: 589-605. PMID 26979352 DOI: 10.1016/j.jaad.2015.08.068  0.044
2022 Snowden B, Lahiri S, Dutton R, Morton L. Achieving and Sustaining Change Through Capacity Building Train-the-Trainer Health Initiatives in Low- and Middle-Income Countries: A Systematic Review. The Journal of Continuing Education in the Health Professions. PMID 36215155 DOI: 10.1097/CEH.0000000000000458  0.043
2022 Pasqual E, Schonfeld S, Morton LM, Villoing D, Lee C, Berrington de González A, Kitahara CM. Reply to P. Petranović Ovčariček et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2200735. PMID 35709425 DOI: 10.1200/JCO.22.00735  0.041
2023 Wardenaar FC, Morton L, Nam K, Lybbert H, Schott K, Shumate C, van der Mars H, Kulinna P. The Development and Efficacy of a High School Athlete Education Program for Safe Nutritional Supplement Use. Journal of Dietary Supplements. 1-22. PMID 38131657 DOI: 10.1080/19390211.2023.2293845  0.038
2012 Morton LM, Phillips TJ. Wound healing update. Seminars in Cutaneous Medicine and Surgery. 31: 33-7. PMID 22361287 DOI: 10.1016/j.sder.2011.11.007  0.037
2013 Powers JG, Morton LM, Phillips TJ. Dressings for chronic wounds. Dermatologic Therapy. 26: 197-206. PMID 23742280 DOI: 10.1111/dth.12055  0.037
2019 Rivers C, Chretien JP, Riley S, Pavlin JA, Woodward A, Brett-Major D, Maljkovic Berry I, Morton L, Jarman RG, Biggerstaff M, Johansson MA, Reich NG, Meyer D, Snyder MR, Pollett S. Using "outbreak science" to strengthen the use of models during epidemics. Nature Communications. 10: 3102. PMID 31308372 DOI: 10.1038/S41467-019-11067-2  0.036
2019 Forshey BM, Morton L, Martin N, Cheng Q, Waters NC, Lee J, Mancuso J. Plasmodium falciparum Rapid Test Failures Threaten Diagnosis and Treatment of U.S. Military Personnel. Military Medicine. PMID 31665418 DOI: 10.1093/milmed/usz256  0.036
2010 Markowitz TM, Markowitz WJ, Morton LM. Mating Habits of New Zealand Dusky Dolphins The Dusky Dolphin. 151-176. DOI: 10.1016/B978-0-12-373723-6.00008-4  0.036
2013 Calcul L, Waterman C, Ma WS, Lebar MD, Harter C, Mutka T, Morton L, Maignan P, Van Olphen A, Kyle DE, Vrijmoed L, Pang KL, Pearce C, Baker BJ. Screening mangrove endophytic fungi for antimalarial natural products. Marine Drugs. 11: 5036-50. PMID 24351903 DOI: 10.3390/Md11125036  0.033
2016 Morton LM. Commentary on clinical and histopathological assessment of facial melasma after low-fluence q-switched neodymium-doped yttrium aluminium garnet laser Dermatologic Surgery. 42: 513-514. DOI: 10.1097/DSS.0000000000000651  0.031
2008 Morton LM. Encouraging participation in medical research: what strategies work? Journal of Clinical Epidemiology. 61: 969-70. PMID 18359193 DOI: 10.1016/j.jclinepi.2007.09.001  0.031
2015 Phillips TJ, Morton LM, Uebelhoer NS, Dover JS. Ablative fractional carbon dioxide laser in the treatment of chronic, posttraumatic, lower-extremity ulcers in elderly patients Jama Dermatology. 151: 868-871. DOI: 10.1001/jamadermatol.2015.0645  0.029
2016 Bushman M, Morton L, Duah N, Quashie N, Abuaku B, Koram KA, Dimbu PR, Plucinski M, Gutman J, Lyaruu P, Kachur SP, de Roode JC, Udhayakumar V. Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum. Proceedings. Biological Sciences / the Royal Society. 283. PMID 26984625 DOI: 10.1098/rspb.2015.3038  0.025
2015 Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, Goldman I, Lucchi N, Stennies G, MacArthur JR, Udhayakumar V. Reply to "no robust evidence of lumefantrine resistance". Antimicrobial Agents and Chemotherapy. 59: 5867-8. PMID 26276896 DOI: 10.1128/AAC.01355-15  0.025
2014 Morton LM. The evolution of laser surgery for acne and other scarring processes Seminars in Cutaneous Medicine and Surgery. 33: 169-175. DOI: 10.12788/j.sder.0118  0.022
2014 Morton LM, Dover JS. Foreseeing the future of skin tightening Dermatologic Surgery. 40: S199-S202. PMID 25417576 DOI: 10.1097/DSS.0000000000000182  0.018
2023 Morton L, Creppage K, Rahman N, Early J, Hartman L, Hydrick A, Kasper M. Challenges and Opportunities in Pathogen Agnostic Sequencing for Public Health Surveillance: Lessons Learned From the Global Emerging Infections Surveillance Program. Health Security. PMID 38054950 DOI: 10.1089/hs.2023.0068  0.013
Hide low-probability matches.